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RESUME
 
Derive des deux tennes grecs « anti» et « biotikos », Ie terme antibiotique 
signifie « contre la vie ». Les antibiotiques attaquent et detruisent les bacteries 
vivantes et les ernpechent de se multiplier dans I'organisme humain. 
Depuis leur premiere utilisation, tout un arsenal d'antibiotiques a ete 
developpe pour Ie traitement de diverses infections chez I'humain. L'utilisation a 
profusion, et dans certains cas aoutrance des antibiotiques pour Ie traitement des 
infections microbiennes, a permis acertaines souches bacteriennes d'acquerir une 
resistance aces medicaments. Dans cette optique une alternative aux antibiotiques 
s'impose de plus en plus. 
La premiere etape de nombreuses infections bacteriennes est la colonisation 
des surfaces epitheliale de l'hote. L'adhesion est mediee par des structures 
presentes a la surface de la cellule bacterienne, appelees adhesines, qui 
interagissent avec des composants presents a la surface de la cellule hote ou a 
hauteur de la matrice extra-cellulaire, appeles recepteurs. Les lectines sont les 
adhesines bacteriennes les plus etudiees. De nature proteique, elles ont ete 
classees en differents groupes sur la base de leurs proprietes d 'hemagglutination, 
leurs ultrastructures et leurs specificites de recepteurs, Les lectines du premier 
groupe sont responsables d 'hemagglutination sensible au mannose et presentent 
une structure de nature fimbriaire (fimbriae de type I, FimH). Les futures 
strategies therapeutiques resident probablement dans 1'utilisation de diverses 
adhesines, comme cibles therapeutiques ou comme porteur depitopes etrangers, 
afin de produire des anticorps contre differents facteurs de virulence. 
Utilisant de nouvelles methodes de C-glycosidations combinees a la 'click 
chemistry' une serie de C-mannosides a ete synthetisee. Le potentiel d'inhibition 
de l'adhesion du FimH de ses glycomimetiques apportera de precieuses 
informations dans le cadre d'une grande etude relation-structure-activite (QSAR). 
Mots-cles : antibiotique, adhesion, lectine, FimH, C-glycosidation, click 
chemistry 
SUMMARY 
Derived from the two Greek terms 'anti' and 'biotikos', the term antibiotic 
means 'against life' . Antibiotics attack, destroy bacteria, and prevent them from 
multiplying in the human organism. 
Since their first use, a whole arsenal of antibiotics was developed for the 
treatment of various infections in humans. In certain cases, antibiotics were used 
in such an excess for microbial infection treatments that made possible for certain 
strains to acquire resistance to these drugs. An alternative to antibiotics is 
increasingly essential. 
The first stage of many bacterial infections is the epithelial colonization on 
the host surfaces. Adhesion is mediated by structures present at the bacterial cell 
surfaces called adhesins, which interact with glycoproteins present at the surface 
of the host cells or on the extracellular matrix. Lectins are the most studied 
bacterial adhesins, classified in various groups on the basis of their property of 
hemagglutination, their ultrastructure, and their specific receptors. The lectins 
responsible for hemagglutination sensitive to mannose can be represented by a 
fimbriated structure (fimbriae of type 1, FimH). The future therapeutic strategies 
may lie in the use of various anti-adhesins, like therapeutic targets or foreign 
carriers of epitopes, capable of triggering antibodies against various factors of 
virulence. 
Using new C-glycosidation methods combined with 'click chemistry', a 
series of C-mannosides was synthesized. The potential inhibition of FimH 
adhesion by these glycomimetics will bring valuable information for the basis of a 
major structure-activity relationship (QSAR). 
Key words : antibiotic, adhesion, lectin, FimH, C-glycosidation, click 
chemistry 
INTRODUCTION 
Since the rise of the earliest civilizations mankind has tried to treat bacterial 
infections with mixed success. Treatments have included use of moldy bread or garlic 
on wounds to prevent infections in ancient Egypt and China as well as bloodletting and 
herbal mixtures for treatment of plague in medieval Europe. Although Arabic 
physicians had knowledge about the benefits of clean environments and fresh air when 
th 
treating patients as early as the 8 century, illnesses were commonly thought to be 
caused by evil spirits or imbalance of the four body fluids , blood, phlegm, black bile 
and yellow bile as stated by the Greek physician Hippocrates. It was not until the late 
th 
19 century, through the work of Pasteur and Koch among others, that infectious 
disease was found to be caused by microbes not visible to the eye. In the forthcoming 
years advances wi th vaccinations and chemical preparations led to treatment of 
bacterial infections like anthrax and syphilis. Eventually the broad-spectrum 
antibiotics Penicillin and Sulfa drugs were introduced through the efforts of Fleming, 
Florey, Chain, and Domagk in the mid 1930's. Since then, thousands of new 
antibacterial agents have been discovered and introduced, giving mankind the ability to 
battle any given bacterial infections and saving millions of lives each year. However, 
over- and under consumption of these drugs, in combination with the quick cell cycle 
of bacteria and their rapid ability to mutate, has led to bacterial strains resistant to many 
known antibiotics, making it crucial to find new therapies to prevent bacterial 
infections. [lJ 
- -- - - - ------ ---
2 
A Escherichia coli 
Escherichia coli, usually abbreviated to E. coli, (coli is Latin for "of the colon") 
discovered by Theodor Escherich, a German pediatrician and bacteriologist, is one of 
the main species of bacteria that live in the lower intestines of mammals, known as 
gut flora. Specimens have also been located on the edge of hot springs. According to 
the US Department of Health and Human Services Centers for Disease Control and 
Prevention, the E. coli strain 0157:H7, one of hundreds of strains of the bacterium E. 
coli, causes illness in humans. Presence in surface water is a common indicator of 
fecal contamination. It belongs among the Enterobacteriaceae and is commonly used 
as a model organism for bacteria in general. One of the root words of the family's 
scientific name, "enteric", refers to the intestine, and is often used synonymously with 
"fecal" 
The number of individual E. coli bacteria in the feces that a human excretes in 
one day averages between 100 billion and 10 trillion. All the different kinds of fecal 
coli bacteria, and all the very similar bacteria that live in the ground (in soil or 
decaying plants, of which the most common is Enterobacter aerogenes), are grouped 
together under the name coliform bacteria. Technically, the "coli form group" is 
defined as all the aerobic and facultative anaerobic, non-spore-forming, 
Gram-negative, rod-shaped bacteria that ferment lactose with the production of gas 
within 48 hours at 35°C (95 OF). In the body, this gas is released as flatulence. E. coli 
cells are elongated, 1-2 /km in length and 0.1-0.5 /km in diameter. 
E. coli can cause several intestinal and extra-intestinal infections such as urinary 
3 
tract infections or UTls (meningitis, peritonitis, mastitis, septicemia and 
gram-negative pneumonia etc) . [2] 
UTls are serious health problems being the second most common of all bacterial 
infections. UTls account for approximately 15% of all antibiotic consumption at a 
cost of $2 billion each year in the US alone. Uropathogenic Escherichia coli (UPEC) 
is the most common cause of infections both in the urethra (urethritis) and the bladder 
(cystitis) in the lower urinary tract, as well as the more severe infections in the 
kidneys (pyelonephritis) that can develop if the infection is not treated in time. 
One of the most important virulence factors in bacteria is their ability to adhere 
to cell tissues. Many Gram-negative bacteria depend on adhesive, supramolecular 
protein appendages that extend from the bacterial surface, so called pili, to recognize, 
attach to and invade host cells. Once inside an environment rich in nutrients they can 
start to replicate which in tum triggers the host's immune response and consequently 
causes an inflammation. 
Figure 1. The pathogenic cascade in UTIs. Pili are required for the adherence (1) and 
invasion (2) of the host and have been proposed to be necessary for both biofilm formation 
in pods (3) and to trigger apoptosis (4). Recurrent infections may come from bacteria that 
have been in hibernation since a previous infection . 
4 
E. coli displays a variety of adhesins and adhesive organelles on their surfaces, 
one of the most important being type 1 pili . Adhesins at the tip of type 1 pili (FimH) 
constitute unique carbohydrate receptors and are responsible for the attachment to 
mannose residues on glycoproteins in the bladder. 
Escherfc hftlCocr 
Fimbriae 
Figure 2. The pilis type of E. Coli 
B Targeting adherence as an antimicrobial chemotherapy 
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Figure 3. The mechanism of antimicrobial chemotherapy [3J. 
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Targeting the bacteria's ability to adhere to host cells is a very attractive way to 
prevent and treat bacterial infections, offering many advantages over conventional 
antimicrobial treatments. The most commonly used antibiotics today are either 
bacteriocidic, i.e. they kill the bacteria by targeting for instance the synthesis of the 
bacterial cell wall (e.g. penicillin), or bacteriostatic, which means that they inhibit cell 
growth and replication by interrupting the bacterial metabolism such as biosynthesis 
of the vitamin folic acid (e.g. Sulfa drugs). Since both types of treatments result in 
that non-resistant bacteria do not multiply or are killed off they leave room for 
resistant strains to flourish, hence resulting in an evolutionary pressure on the bacteria 
that are beneficial for mutant strains that have gained resistance to the drugs . 
However, if the bacterial pathogenicity is targeted, the microbe will only be 
disarmed, i.e . unable to cause an infection but otherwise thriving. This will ease the 
natural selection making it harder for resistant strains to emerge. Targeting highly 
conserved adherence mechanisms would also be advantageous since the preservation 
of those mechanisms alone indicates that viable mutations in these pathways are less 
likely to occur. Furthermore, given that the pilus assembly is highly conserved within 
different kinds of bacteria, it provides the opportunity to develop broad-spectrum 
chemotherapies. 
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C The structure of FimH 
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Figure 4: The crystalline structure of FimH. (4) 
Gram-negative pathogens, E. coli can express a number of adhesive 
organelles assembled by several distinct pathways allowing them to target and 
colonize specific niches in the host. Type 1 fimbriae (Fim) is a well characterized 
adhesin of E.coli. Of the various E.Coli adhesins, type 1 pili, by far the most 
prevalent, bind to high-mannose glycoproteins. FimH is a two-domain adhesin 
'protein at the end of the tip fibrillum, responsible for the mannose sensitive bacterial 
adhesion. The amino-terminal lectin domain (residues 1-158) is joined to the 
carboxy-terminal pilin domain (residues 159-279) that links the adhesin to the rest of 
the pilus. FimH mediated adhesion can be inhibited by D-mannose (Old, 1972; Hung 
et al., 2002) and a variety of natural and synthetic saccharides containing terminal 
mannose residues (Firon et al., 1982; 1983; 1984; 1987; Neeser et al., 1986; Lindhorst 
et al. , 1998; Nagahori et al ., 2002). Blocking of the FimH-receptor interaction has 
been shown to prevent bacterial adhesion to the epithelium and thereby infections 
7 
(Langermann et al., 1997; 2000; Thankavel et al ., 1997; Langermann and Ballou, 
2003). [5] 
By crystal structures of the FimH lectin domain of E. coli, one found butyl 
a-D-mannoside in the mannose binding site and furthermore simple alkyl mannosides 
bind with nanomolar affinities to FimH. This indicated that small-molecule inhibitors, 
targeting with high-affinity the FimH mannose binding site, may prevent infections 
by interfering with the attachment of E. coli to the cells 
Table 1. Kd and calculated ~Go for a series of alkyl and aryl mannosides. 
Kd SPR !1(.;0SPR Kd displace !1G0 displace
 
Ligand (nM) (kcal mor ') (nM) (kcal mor ')
 
Mannose 2.3 x 10:< -7.6 4.1 x 108 -7.3 
Melhylaman 2.2 x 103 -7.7 2.4 x 108 -7.6 
Ethylornan 1.2 x 108 -8.1 730 -8.3 
Propylcrnan 300 -8.9 400 -8.7 
BUlylo:rnan 151 -9.3 150 -9 .3 
Pentylornan 25 -10.4 200 -9 .1 
Hexylo:man 10 -10.9 too -9.5 
Heptylo:man 5 -11.3 32 -10.2 
Ootylornan 22 -10.4 28 -10.3 
PNPaMan 44 -10.0 26 -10.3 
MeUmlxdv1an 20 -10.5 12 -10.13 
The SPR and displacement binding experiments define heptyl 
a-D-mannopyranoside as the best binder. 
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o Mannose binding pocket 
A B 
Figure 5: Stereo views ofF imH. 
A Three-dimensional structure of the FimH lectin domain is an elongated l l-stranded 
(-barrel with an immunoglobulin fold . 
B Focus on the mannose-binding pocket, in the same orientation as (A), sho wing the 
hydrophobic contacts (wi thin 4.6 A, orange) with butyl a-D-mannoside and the water 
network (salmon pink) present at 01. 
C Surface pre sent ation (wheat yellow) of the different alkyl conformations of the butyl 
(-D-mannoside in the crystal structures of FimH truncates I and 2: FimHtr I butyl group 
(cyan), FimHtrl Tyr48 (marine blue) , FimHtr2 bu tyl group and Tyr48 (salmon pink) , 
Tyrl 37 (violet), Ile52 (pink). 
As described previously (Hung et al. , 2002), the mannose ring makes 10 direct 
hydrogen bonds to the side-chains of residues Asp54, Gln133, Asn135 and Asp140, 
9 
and to the main chain of Phe 1 and Asp47, and indirect water-mediated hydrogen 
bonds via 02 to the side-chain of Glu 133 and to the main chain oxygen of Phe1 and 
Glyl4. The alpha-anomeric hydroxyl group 01 of mannose is involved in a 
hydrogen-bonding water network with the Asn 138 and Asp 140 side-chains, through a 
water molecule (wat 2, Figure 5. B) that is conserved between the two truncate 
structures . The positions of the other water molecules participating in this network 
depend on the crystal packing of FimHtrl and FimHtr2. 
E Interactions of the butyl Aglycon with FimH 
The butyl moiety of butyl a-D-mannopyranoside extends out of the 
mannose-binding pocket towards Tyr48 and Tyr137, making van der Waals contacts 
to both tyrosine rings and Ile52 (Figure 5. B and C) . These residues are part of two 
loops (b4-b5 and b1O-b 11) that form the higher rear end of a hydrophobic collar 
around the binding site (Figure 5. A and B) . In both subunits of the FimHtr2 (FimH 
truncate 2, from the E. coli K-12 laboratory strain MG 1655) structure, the Tyr48 and 
Tyr137 side-chains are in the same, almost parallel, orientation as in the FimC:FimH 
structure, forming a gatelike structure at the back of the binding site (Figure 5. C). 
The closest hydrophobic interactions (3.1-3.6 A) with the alkyl chain are made 
between Tyr48 and the two non-terminal atoms of the butyl group. In the FimHtrl 
(FimH truncate 1, originating from the UPEC strain J96) structure, a crystal contact to 
Val155 of a neighbouring molecule prevents the parallel orientation of the Tyr48 ring, 
which instead is packed edge-to-face with Tyr13 7 (Figure 5. B). The repositioning of 
Tyr48 is accompanied by a change in the conformation of the butyl chain of the 
ligand, with the butyl chain in a more extended conformation than in the FimHtr2 
10 
structure, and with the four carbon atoms nearly in one plane (Figure 5. B and C). 
The new conformations of Tyr48 and the butyl moiety result in an almost parallel 
stacking of the aromatic ring of Tyr48 onto the butyl plane, with the closest 
hydrophobic interactions (3.7 A) involving the two terminal carbon atoms of the butyl 
(Figure 5. B). 
Surface plasmon resonance, as well as equilibrium binding, indicate that FimH 
binds butyl cx-D-mannoside 15-30 times stronger than cx-D-mannose. The importance 
of the added hydrophobic contacts is clearly demonstrated by the binding of alkyl 
mannosides (Table 1). The best binding alkyl mannosides bind a few hundred times 
stronger than mannose. 
-7.5 
• 
.'\ slope -0.64 +/- 0.03 
-8.0 
• 
correlation -0.99 +/- 0.18 
-
-8.5 · 
~ 
L 
0 -9.0 • 
E 
~ -9.5 · 
• 
0 
..:ll:0-10.0 
<1 
-10.5 • • 
-11.0 • 
-11.5 • -, 
I I I I I 
0 2 4 6 8 
Number of carbon atoms 
Figure 6: Linear free energy relationship for the alkyl chain on alkyl mannoside. A linear fit 
was made, using 1 up to 7 methyl groups, with the program MICROCAL ORIGIN 5.0. 
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Interestingly, the butyl moiety takes on significantly different conformations in 
FimHtrl and FimHtr2 (Figure 5.C), indicating that intrinsic conformational 
flexibility in the aglycon is allowed . Indeed, in spite of the larger flexibility expected 
for longer alkyl mannosides, the binding energy increases linearly with increasing 
length of the alkyl chain between one and seven carbon atoms (Figure 6). The 
affinity reaches its maximum for mannoside with a seven-carbon alkyl, heptyl 
a-D-mannopyranoside and SPR measurements suggest that the affinity decreases 
from eight carbon atoms on . Evidently, the eighth carbon atom goes beyond the 
hydrophobic interaction surface and protein edge, which is penalized with a decrease 
in affinity. We propose that the affinity increase results from an increased interaction 
surface with the hydrophobic gateway. Alkyl aglycons fit well in the tyrosine gate 
and, as observed in the two crystal structures, in at least two different conformations 
that depend on the conformation of Tyr48. Nevertheless this flexibility may indicate 
that aglycons can interact rather non-specifically with the hydrophobic gateway, 
resulting in a lOO- to lOOO-fold increase in affinity. 
F C-Mannosides 
All molecules we have discussed above are O-mannosides which, unfortunately, 
aren't stable in vivo since, they can be hydrolyzed by enzymes. Therefore, we have to 
synthesize another series of C-mannosides which are more stable in vivo than 
O-mannosides. 
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G C-G1ycosides 
L INTRODUCTION 
C-glycosides in which the glycosidic oxygen is replaced by a carbon atom, are 
an important branch of sugar chemistry. Many routes are available for their synthesis 
and a few are presented herein. 
II. CONCERTED REACTIONS 
ILl Sigmatropic Rearrangements 
Scheme I 
:(:rOSiMe3 ~ 
1 2 
Silyl enol ether I was converted to 2 by Claisen methodology to 
stereospecifically synthesize a C-glycoside (Scheme 1). [6] 
11.2 Cycloadditions 
The Diels-Alder reaction, which is possibly the most important reaction III 
organic chemistry, has also found application in C-glycoside synthesis. 
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Scbeme 2 
OBn 
Bno?= 
PhS 0rO~ -I OMe + II -
PhS 
AcO 
several steps 
OAc 
AcO~q ~~OMe 
--- ­ ACO~ 
AcO 
3 4 5 OMe 6 
The cycloadduct 5 is formed in good yield by reaction of hetero diene 3 with the 
substituted styrene 4 and further steps gave the C-gl ycoside 6. [7] 
III. WITTIG APPROACHES 
The Wittig reaction has also been extensively applied to C-glycoside syhthesis. 
Ylides can react with lactols to yield open chain sugars which either in situ to produce 
a C-glycoside, or can be isolated and cyclized via other means Both Wittig like 
reactions on sugar lactones and reactions of anomeric phosphoranes with suitable 
carbonyl compounds have been used to construct exo-methylenic sugars. 
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I1L1 Reactions ofHemiacetals followed by ring Closure. 
Scheme 3 
H H
 
H3C\~Q H3C~~ __OH
 
O-HO~C02MeHO~ 
OH OH OH 
9 
7 
H J KOH/MeOH 
H3C~~ __O 
O·HO~C02Me 
OH 
10 
Re action of compound 7 with Witt ig reagent 8 gave compound 9 in good yield. 
Addition of 9 to potassium hydroxide in methanol produced mainly the ~-isomer 10. 
[8] 
I1I.2 Reactions of Sugar Lactones 
Scheme 4 
co. /C~AI ..... Me 
Cp......TI,C...... 'Me Cp=BnOjOyO 0 Bno!o'(CH2 H2 
BnO" 'y"'OBn BnO" 'y"'OBn 12 
OBn OBn 
11 13 
Latone 11 is treated with Tebbe's reagent 12, and the exo-methylenic sugar 13 is 
produced. [9] 
15 
111.3 Reactions ofAnomeric Phosphoranes 
Scheme 5 
+ ­
BnO,OyPPh3 BrBno:yol PPh3 HBr i) BuLi/THF, 100f0HMPA 
•BnO" BnO" 'Y
 
OBn
 OBn 
14 15 
BnO HO
° -:?' i) Et3N/Pd/C, 1 atm/H2 , EtOH 
BnO" HO" 
ii) Pd/C, 1 atrn/H, OBn 
16 17 
The Wittig reagent was derived from the sugar itself, to give the phosphonium 
bromide 15. This material was then deprotonated and treated with octanal to form the 
C-glycoside 16. Reduction of the double bond followed by benzyl group removal 
afforded the 2-deoxy-C-glycosideI7. [10] 
IV. PALLADIUM MEDIATED REACTIONS 
IV.1 n-Allyl Complexes 
Scheme 6 
Pd(dbah + DIPHOS 
•-/:y
on 
18 19 
16 
The reaction of 18 with the enolate of malonic ester was carried out in THF in 
the presence of bis(dibenzylideneacetone)-Pd(O) and bis(diphenylphosphino)ethane 
and gave 19 in 56% yield. [ II ] 
IV.2 Stille Couplings 
Scheme 7 
OTBS 
Ns nBU3 Q-BrI . TBSO'" 
OTBS OTBS 
20 21 
Stannane 20 reacted with bromobenzene in THF in the presence of palladium 
catalyst to give 21 in 70% yield . [12] 
V. SUGAR ELECTROPHILES 
V.l Lactols (Sakurai reaction) 
Scheme 8 
OBn OBn 0 
BI10~
 BnO BnO OH 
TMSOTf 
22 82% 24 
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The reaction of compound 22 with 2-methyltrimethylallylsilane 23 was carried 
out in the presence of the Lewis-acid, the main product, the a-isomer was formed in 
82% yield . This facial preference is due to axial attack, under the influence of the 
anomeric effect, on the pyroxonium triflate. [13] 
V.2 Glycosides 
Scheme 9 
OBn
 
OBn
 
AgOTf
 
BnO ~ 0
Bn'O~S1JN" \ OTMSBnO // ~Ph o25 
2726 
Treatment of the thiopyridyl glycoside 25 with silyl enol ether 26 in the presence 
of silver triflate produced the C-glycoside 27. [14] 
V.3 Anomeric Esters 
Scheme 10 
OBn 
~O\ N02 Brs~o~ ~- + OMe 
MeO15OMeO~N02 .0 80% 
o 
28 29 
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Treatment of activated glucopyranosyl ester 28 with 1,3,5-trimethoxybenzene in 
the presence of aluminum trichloride gave the ~-isomer 29 in 80% yield. This type of 
methodology provides access to oxygenated aryl C-glycosides. [1 5] 
VA Anomeric Imidates 
Scheme 11 
OBnNrt
e 
Meo
OMe ~ isomer 
exclusively 31 
Reaction of the glucosyl imidate 30 with 1,3-dimethoxybenzene in the presence 
of boron trifluoride etherate gave the ~-isomer 31 exclusively. [16] 
V.5 Glycosyl Halides 
Scheme 12 
• 
TMSOTf 
75% 
32 33 
ex: ~ =10: 1 
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The use of pyranosyl chlorides in Lewis-acid catalyzed allylations also provides 
good yields of a -C-glycosides. Treatment of compound 32 with trimethylallylsilane 
in the presence of trimethylsilyl triflate provides a 75% yield of both anomers, with 
the a-anomer 31 favored by a factor of 10:1. (17] 
V.6 Glycals 
Scheme 13 
OAc 
0 ·,'OAC ~."OAC 
lLO~OAC ~" " ~O~OAC 
34 35 
Allylation of 34 under standard conditions described above gave the expected 
product 35. [1 8] 
V.7 Enitols & Anhydro Sugars 
Scheme 14 
ACO:e ACO~OCH3 
OAc OAc 
AcO AcO 
o 
37 OH36 
Bn0:::l Bn0:::l 
Bnq}--O Bnq}--Ois ~
 BnO CH3BnO 
38 39 
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1,2-Anhydro sugars can also serve as useful precursors to C-glycosides. 
Reaction of 3,4,6-tri-O-acetyl-l ,2-anhydro-a-D-glucopyranose 36 with lithium 
dimethylcuprate in diethyl ether provided 37. The reaction proceeds by attack at C-l. 
Likewise in the manna series, reaction of 38 gave compound 39. [19] 
V.8 Sugar Lactones (Kishi's reaction) 
Scheme 15 
OBn 0 Li ­ (CH2hOBn 
41BI1..0 
C3nO ~BnO '\ 
o 
40 
OBnOBn OBn 
BI1..0~'--:::: (CH2hOBn1:3 nO zz> 
BnO 
H 
45 43 
~ HrLindlar 
OBn 
44 
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Addition of the lithium acetylide 41 to the protected gluconolactone 40 gave a 
mixture of epimers 42. Stereoselective reduction with triethylsilane and boron 
trifluoride etherate then gave ~-anomer 43 as the exclusive product. Then the .triple 
bond can be manipulated to give either the Z-isomer 44 or the E-isomer 45. [20] 
VI. NUCLEOPHILIC GLYCOSIDES 
VI.1 C-I-Lithio Derivatives 
Scheme 16 
OBn OH OBn OH 
Ra-Ni 
OBn Bno~~ /~~PhBno~ /;}, LDA B!f3~~PhB~O~~OB~Oq~o PhCHO I
 
I Ph
 
46 Ph 4847 
An unsatuated sulfoxide 46 which is deprotonated with LDA and subsequently 
treated with benzaldehyde afforded the C-glycoside 47. The reaction of Raney nickel 
on 47 gave the desulfurized product 48. [21] 
VI.2 Anomeric Stannanes 
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Scheme 17 
OBn OBnBno~OB~
 BnO~O\ BnO~BnO R2BnoD BnO~ 
R1 
51 R2 =SnBu3 
[ 50 BuLi [ 
52 53 R2 =Li 
BuLi 
PhCHO [ 54 
PhCHO [ 
55 
OH 
R2 = ---< 
56 Ph 
49 can be converted either to the u- or ~-tin glycosides. Treatment of 51 or 52 
with n-butyllithium and reaction with an appropriate electrophile then yields 54 and 
55. It should be noted that both the u- and ~-tin glycosides are available from the 
same readily available c -pyranosyl chloride. However, this method is restricted to 
2-deoxyglycosides since an intermediate anion of structure 56 would undergo 
elimination as shown above. [22] However this can be avoided by the use of SmI2, and 
glycosyl sulfones. [23] 
Scheme 18 
0=0
BnO~OBn0 
58BnO 
AcNH ~ S02\~IJ 
N 
57 75% 
59 
a:I3=10:1 
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Vr.3 Anomeric Transition Metal Complexes 
Scheme 19 
OAcOAC 0 CO(CO)8 
AcO ACO~--O
AcO ~ OAc ACO~ 
OAc OAc OSiEt3 
60 61 
A number of other transition metals have been used to construct C-glycosides, 
and Scheme 19 shows a simple method for generating a C-glycoside in a highly 
stereospecific manner. Reaction of 1, 2 , 3 ,4 , 6 -penta-O-acetyl - ~ -D-glucose 60 with 
Co(COh in the presence of triethylsilane and carbon monoxide gave the C-glycoside 
61. [24] 
VIA Nitro Compounds. 
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Scheme 20 
OAc 
OAC 0 KF, MeCN, 18-C-6 
AcO + 
AcO 0T­~ CH2N02 OAc yQ
62 63 
OH OAc 
OH
 
protective group removal
 
66 
OH 
If the interglycosidic oxygen in a disaccharide is replaced by a methylene unit, 
one obtains a non-metabolizable C-disaccharide. Nitroaldol condensation of 62 with 
aldehyde 63 in acetonitrile, containing potassium fluoride and 18-Crown-6, afforded 
the aldol product 64. Acetylation, elimination, and reduction of the double bond by 
the action of sodium borohydride furnished 65 as a mixture of epimers. Tin hydride 
reduction of the nitro group followed by deprotection gave the C-glycosides 66. [25] 
VII. FREE RADICAL APPROACHES 
VII.! Intermolecular Additions 
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Scheme 21 
OAc 
OAcACO~AcO 
AcO 
Br 
67 
+ 
70% HO 
69 
68 
Reaction of glucosyl bromides 67 with 68 and tributyltin hydride under 
photolytic conditions gave the C-glycosides 69. [26] 
VII.2 Intramolecular Additions 
Scheme 22 
-i o~ i) AIBN ii) BU3SnH 
CN 
o	 iii) ~CN
 
0Br
 OEtEtO 
70	 71 
Reaction of 70 under free radical conditions with acrylonitrile afforded, in good 
26 
yield, compound 71. [27] 
H Rational design 
Rational design is the term used for a wide variety of different methods where 
structural knowledge of the drug target and/or a known ligand is used to virtually 
design compounds with a potentially better biological response. 
Structure based design 
A model of the drug target, derived either by X-ray crystallography, solution 
NMR spectroscopy or homology models made from a known protein of a similar 
class, is used as a template for the design of potential binders. By examination of the 
receptors, various molecular scaffolds can be appropriately substituted to directly 
exploit the structural characteristics of the receptor binding site. Hence, a good match 
with the receptor in regards to steric fit, complementary surfaces, hydrogen bonding, 
and so forth can be achieved. Suitable scaffolds can be obtained in different ways, 
often depending on the circumstances; modification of a known ligand, so called 
structure based ligand design, is an approach that has a high probability of success 
and is most often used when the structure for a ligand-receptor complex is known. If 
only the structure of the receptor is known, other approaches such as virtual screening, 
i.e. sampling of databases of molecular structures through the receptor, or de novo 
design , where the molecule is spawned from a seed structure within the active site, 
needs to be considered. 
Structure based design has several weaknesses such as the difficulty to 
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correctly predict the affinity of the virtual complex and the fact that simplistic 
assumptions of the conformational change of both the ligand and the receptor upon 
binding often have to be made to speed up calculations. However, there are sti II 
several drugs on the market, such as HIV-potease inhibitors (e.g. Indinavir, Ritonivir) 
and the influenza drug Relenza, that authenticate the effectiveness of structure based 
design. 
The aims of this thesis are the design, synthesis, and biological evaluations of 
compounds targeting adherence in E. coli, by inhibiting the binding of FimH pili to 
epithelial host cells. Efforts have been put into the synthesis of compounds targeting 
carbohydrate receptors for the type 1 pili adhesin FimH thereby attempting to prevent 
bacterial attachment to host epithelial cells. 
SYNTHETIC STRATEGIES 
Introduction 
Taking into account the objectives defined previously, we undertook the 
synthesis of mannose derivatives, modified at position 1 and position 6 to increase 
their affinities within FimH-subunit binding site. 
In literature, mannose derivatives modified at position 1 have been most 
successful, so we began to synthesize the derivatives modified at position 1. 
Scheme 23: synthetic strategies 
<::::: Modifications at position 6 
H~OHO~O 
HO 
HO 
OMe <=== Modifications at position I 
I Modifications at position 1
 
Figure 7: Interaction between the mannosides aglycon and of the FimH binding site .
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In this figure , the butyl group at position 1 of mannose interacts with the 
hydrophobic gateway formed by Tyr48 , Tyr137 and Ile52, so our purpose is to 
modify the group at position 1 to increase hydrophobic interaction (mainly TI:-TI: 
interactions) between the ligand and FimH. 
Because O-glycosides can be hydrolyzed by enzyme in vivo, we will synthesize 
another series of mannosides: the C-mannosides which are more stable in vivo than 
the O-glycosides. Since 'click chemistry' easily enables the synthesis of new 
pharmacophores, we combined these two methods to synthesize the following 
compounds. 
Scheme 24 : target compounds 
o 
Retrosynthetic analysis of this compound is as follows: 
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Scheme 25: retrosynthetic analysis of target compounds 
click chemistry 
> 
o 
HXJ;0 Saku!"ai type HO HO HO H N CO R2HO H~O
HO -0 reaction HO -0 oxidation ~  2 ~ 2 
HO < HO <; === H~O + ­¢: ~ OMe <;I C02H 
Initially, the cyclic triazoles can be formed by click chemistry; the target 
compounds can be broken up into two synthons : the azide and the alkyne derivatives. 
The alkyne compound, can be formed by propargylglycine and 
2-(a-D-mannopyranosyl)ethanoic acid by amide formation reaction, The acid can be 
formed starting with methyl a-D-mannopyranoside via Sakurai standard reaction 
followed by oxidation reaction. Thus the target compound can be broken up into three 
synthons : azide derivatives, propargylglycine and 2-(a-D-mannopyranosyl) 
ethanoic acid. 
1,2,3-Triazoles are attractive constructs, and because of their unique chemical 
properties and structure should find many applications in organic, orgametallic, and 
medicinal chemistry. Not present in natural products, they are remarkably stable to 
metabolic transformations, such as oxidation, reduction, and both basic and acidic 
hydrolysis. Furthermore, 1,2,3-triazole moieties are emerging as powerful 
pharmacophores in their own right. [28] 
Several methods have been described for the synthesis of 1,2,3-triazoles. Among 
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them, the most important and useful one is the cycloaddition of azide with alkyne. 
Sharpless used Cu(I) salt as a catalyst to promote the reaction of azides with terminal 
alkynes to give, in high regioselectivity, the 1,4-substituted products. This kind of 
reaction is now called 'Click Chemistry'. [29] 
Scbeme 26: Proposed Reaction Mechanism of click chemistry 
R1 CuLn_1)=( 
N"N,N 'R2 
R1y ·,::-C L 
I U n-2 ~ 76 
N"N' N'R2 
75 
c 
1 
e 
R1 CuLn_I 2 ABN=N ;N 'R2 
e 
74 R1 CuLn_1~ 73 
e 
N2N-N-R2 
e 
The first step in the mechanism of the 'Click Chemistry' is the conversion of the 
alkyne 72 to the copper acetylide 73, the azide then replaces one of the ligands and 
binds to the copper atom via the nitrogen proximal to carbon, forming intermediate 
74. After that , the distal nitrogen of the azide in 74 attacks the C-2 carbon of the 
acetylide, forming the unusual six-membered copper (III) metallacycle 75. From 75, 
triazolyl-copper derivative 76 is formed by ring contraction. Proteolysis of 76 
releases the triazole product, thereby completing the catalytic cycle. [30] 
We then synthesized these three synthons respectively. 
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Chapter 1 Synthesis of azide derivatives 
Two methods are used for the efficient single step preparation of desired azides 
starting from halides or amines . 
1.1 Starting from halides, azide derivatives can be synthesized by simple SN2 
reactions. 
Scheme 27: Preparation of azide derivative starting from halide 
RX 
Halides were treated with sodium azide in appropriate reaction, furnishing the 
corresponding azide derivatives . [31] 
We have synthesized a series of azide derivatives from alkyl halides (See Table 
2). 
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Table 2: Halides, corresponding azides, and reaction cond itions. 
Halides Azides NaN3eq Solvant T (0C) Time (h) Yield (%) 
Mel MeN3 1.2 DMF/H2O 55 24 15 
16 731.2 DMF/H2O 85/'Br /'N3 
/'vBr /'yN3 1.2 DMF/H2O 85 16 91 
Br N3 
A A 1.2 DMF/H2O 85 16 88 
,f'vBr ,fVN3 1.2 DMF/H2O 85 16 
93 
161.2 DMF/H2O 85 55-tel +N3 
Preparation other azides cyclic alkyl halides, benzyl halide and ester halide, 
react with sodium azide catalyzed by PTe in appropriate conditions to provide the 
corresponding azides (Table 3) 
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Table 3: Other halide, corresponding azides , and reaction conditions 
Halide Azide NaN 3 (eq) Solvant PTC T (OC) Time (h) Yield (%) 
6 
Br 
0 
N3 
H2O2 BU4NHBr,5% 100 16 75
 
Q--Br Q--N3
 2 BU4NHBr,5% 100 16 80H2O 
o> (y'N3 2 Et2O/H2O BU4NHS04,10% TP. 24 Quant 
10\ fo\' 1.5 Et2O/H2O BU4N HS04,1 0% TP. 24 92 Br N3 
0 0(0/ (0/ 24Et2O/H 2O BU4NHS04,10% TP. 612Br N3 
0 0 
2 Et2O/H 2O BU4NHS04,10% TP. 24 Quantro"'" r o"'" Br N3 
1.2. Starting from amino acid, azides can be formed by diazotransfer reaction 
Scheme 28: Preparation of azide derivative starting from amino acid 
H20,CH2CI 2 
OOC,2h 
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1.5 K2C03, 1% CUS04 
H20, CH30H, CH2CI2 
First, trifluoromethanesulfonic anhydride (Tf20) was reacted with a large excess 
of sodium azide in a mixed-solvent system. The crude trifluoromethanesulfonyl azide 
extract was then reacted with a series of amino acids, a reaction catalyzed by copper 
sulfate in another solvent mixture (H20/CH30H). The corresponding azides were 
obtained mostly in good yields. [32] 
By this method, several amino acids and tyramine were transformed into the 
corresponding azides with various yields (see Table 4). 
The mechanism of the diazotransfer reaction is currently unknow. Chi-Huey 
Wong [33] suggested a mechanism as shown in Scheme 29. 
Scheme 29: The mechanism of the diazotransfer reaction 
e @ 
RN=Cu = RN -Cu 
B c 
e @ 
RN-Cu 
\~(@ J
 
Cu=N-TfN=N-N-Tf
- E FD 
Amine A, complexation to the copper catalyst, under basic conditions, may 
provide C, nucleophilic attack by C on the highly electrophilic triflyl azide, might 
form the copper-stabilized mix ed tetrazene E, possibly via a reverse [3 + 2] dipolar 
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Chapter 2 Preparation of
 
L-Propargylglycine methyl ester hydrochloride (L-Pra)
 
The titled compound was synthesized by a known method which is described 
below. [341 
Scheme 30: L-Propargylglycine methyl ester hydrochloride (L-Pra) 
1) Na, EtOH, Quant ~ KOH/EtOH, 0.3 M, 20 °C, 3h, 95% 
2) Br~ 48% Et02Cfc02Et NHAc 1 
77 
~
 Dioxane reflux 
KOH/EtOH, 0.3 M, 20 °C. 12h, 86% 
Et02cfc02H81% f\IHAc 
78 
MeOH, Quant.
 
81 82
 
The first step in the synthesis of L-propargylglycine was the condensation of the 
sodium salt of diethyl a-acetamidomalonate and propargyl bromide to yield diethyl 
c-acetamido-c-propargylrnalonate 77. This was converted by the usual procedure via 
monoethyl n-acetamido-n-propargylrnalonate 78 and ethyl 0 , 
L-N-acetyl-propargylglycinate 79 to 0, L-N-acetyl-propargylglycine 80. 
L-Propargylglycine 81 was obtained in good yield from 80 by stereospecific 
hydrolysis of the acetamide group with porcine kidney acetylase. 
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The enantiomeric purity of 81 was confirmed by optical rotation [a]2oD-31.O (c 
= 1, H20 ), lit: [a]2oD-35.0 (c = 1, H20 ); melting point, 230°C (decomp. beginning at 
210 0q, lit 230°C (decomp. beginning at 210°C). 
To further establish the enantiomeric purity of L-propargyl glycine obtained by 
enzymatic hydrolysis and to study the precision of hydrolysis carried out by porcine 
kidney acylase acylase, we have adopted a method to introduce another chiral centre 
and make the protons on L-propargyl glycine methyl ester diastereotopic which are 
non equivalant and than can be separated on HI NMR. In this experiment we chose 
Mosher acid chloride to make Mosher amide of L-propargyl glycine methyl ester and 
racemic propargyl glycine methyl ester and characterized by H1NMR. NMR of 
Mosher amide of racemic propargyl glycine methyl ester has shown two sets of peaks 
corresponding to both the isomers of racemic propargyl glycine methyl ester at 1:1 
ratio showing the presence of 1:1 mixture of both isomers, whereas in case of Mosher 
amide of L-propargyl glycine methyl ester there are only one set of peaks 
corresponding to L-propargyl glycine methyl ester indicating the presence of single 
isomer (see appendix 1). 
Finally, 81 was esterified by methanol and thionyl chloride, to give 
L-Propargylglycine methyl ester hydrochloride 82. 
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Chapter 3 Preparation of 
2-(tetra-O-acetyl-a-D-mannopyranosyl)ethanoic acid 
The synthesis of the known titled compound IS complex . First, 
2-(tetra-O-benzyl-cx.-D-mannopyranosyl) ethanoic acid was synthesized using a 
published method. 
Scheme 31: 2-(tetra-O-benzyl-a-D-mannopyranosyl)ethanoic acid 
~O NaH, BnBr ~OH~ BnX1;
H~O B~~O 
DIVIF, TBAIOMe OMe 
95%83 84 
~TM S 
TMSOTf, CH3CN 
85% 
1/ 0 3, -78°C, Me2S BnO ~OBnBnO 2/ Jones Reagent BnO 
~ 
C02H 75% 
86 85 
Methyl cx.-D-mannopyranoside 83 was protected by benzyl bromide, [35J to yield 
methyl 2, 3, 4, 6-tetra-O-benzyl-a-D-mannopyranoside 84, which was then activated 
with TMSOTf and coupled to allyl trimethylsilane to provide 
3-(tetra-O-benzyl-a -D-mannoppyranosyl)-1-propene 85.[36] Compound 85 was 
oxidized by ozone and Jones reagent to afford 
2-(tetra-O-benzyl-a-D-mannopyranosyl)ethanoic acid 86. 
By this method, we obtained the a-anomer exclusively; no trace of the ~-isomer 
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were detected by NrvlR spectroscopy. 
Scheme 32: synthesis of target product 
Bn~oBnO
-0 Bn~oBnO_ oBnO +	 BnOBnO BnO 
~ yC02MeC02H 
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Thus we have 2-(tetra-O-benzyl-u-D-Mannopyranosyl)ethanoic acid 86, it 
reacted with L-propargylglycine methyl ester hydrochloride 82 catalyzed by BOP 
reagent. The obtained intermediary compound 87 was then reacted with a series of 
azides (R 1N]) to obtain another series of compounds 88 . 
Unfortunately, the deprotection of the benzyl group was found out to be 
somewhat difficult. We have tried following methods, but none of them gave a good 
result: 
A:	 H2, Pd (OH )2/C , 20%, Ethanol, HCI , T.P. 
Reduced with hydrogen, catalyzed with palladium hydroxide in ethanol with a 
little hydrochloric acid. 
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B:	 Hz, Pd (OH)z/C, 20%, Hexane, EtOH, Reflux. 
Reduced with hydrogen, catalyzed with palladium hydroxide In hexane and 
ethanol refluxed overnight; 
c.	 HCOOH, Pd/C, 10%, MeOH, Reflux. 
Reduced with formic acid, catalyzed with 10% palladium on carbon in methanol, 
refluxed overnight; [37] 
D:	 HCOONH4, Pd/C, 10%, MeOH, Reflux. 
Reduced with ammonium formate, catalyzed with 10% palladium on carbon in 
methanol, refluxed overnight; [3 8] 
E:	 Li1NH3, THF, -78°C. 
Reduced with lithium and liquid ammonia at -78 °C (Birch conditions) 
F:	 Brz, CCI4, hv. 
Reduced with bromide by radical reaction; [39] 
G:	 EtSH, BF3 :EtzO, R.T. 
Reduced with thioethanol in presence ofBF3:EtzO. 
The reasons for failure remain unclear, so instead, we protected the sugar with 
acetic anhydride , because the acetate group could be easily deprotected under 
Zernplen conditions . 
Scheme 33: 3-(tetra-O-acetyl-a-D-mannoppyranosyl)-l-propene 
HO~O	 A~Oc O ~ A~OTMS cO~OH.~ 	 A 0 HO
HO	 - A),~O ~ • ),cO 
Pyridine SF Et 0, CH CI 
OMe OMe 3. 2 2 2 45%(0) (3 days) ~ 
76% 
89	 9083 
Methyl a-D-mannopyranoside 83 was protected with acetic anhydride In 
pyridine, a methyl tetra-O-acetyl-a-D-mannoppyranoside 89 was obtained with 
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excellent yield, which was then activated with BF3:Et20 and coupled to allyl 
trimethylsilane to provide allyl mannoside 90. (40) 
At this point, we encountered another problem; the resulting product 90 was 
obtained as an inseparable mixture of anomers. Thus we had to combine these two 
above methods to synthesize the pure 2-(tetra-O-acetyl-a-D-mannopyranosyl) 
ethanoic acid a-anomer that was formed exclusively and was easily deprotected . 
Scheme 34: 2-(tetra-O-acetyl-a-D-mannopyranosyl)ethanoic acid 
HO BnO BnO Bn~oHO BnO~O~O NaH, BnBr -0 ~TMS BIlO H~O • BnO • l::lnO
 DMF 92. Bn~ TMSOTf, GH,GN 
OMe ' a OMe 85% .0­
83 84 85 
1) Li, NH3 (I) -78 °C 
75% (0) 
2) AC20. Pyr 
AcOAcOAC~O-0 AC~OAcO 1)03,-78°C AC~OACO_ OKMn04 
AcO AcO ~O CH2CI2 AcO t-BuOH AcO • AcO
• 2) Zn, r.t. .0­C02H 75% CHO 
93 92 91 
Methyl a-D-mannopyranoside 83 was actived by sodium hydride and protected 
with bromobenzene to provide methyl 2,3,4,6-tetra-O-benzyl a-D-mannopyranoside 
84, which was activated with TMSOTf and coupled to allyl trimethylsilane to provide 
3-(tetra-O-benzyl-a-D-mannopyranosyl)-1-propene 85. Compound 85 was 
deprotected using Birch conditions and reprotected with acetic anhydride, to give 
3-(tetra-O-acetyl-a-D-mannoppyranosyl)-1-propene 91. The purity of compound 91 
was confirmed by IH NMR (the purity was above 98%). Compound 91 was then 
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ozonolysed and reduced using ZInC to give the corresponding aldehyde: 
2-(tetra-O-acetyl-a-D-mannopyranosyl) ethanal 92. This was oxidized by potassium 
permanganate to give 2-(tetra-O-acetyl-a-D-mannopyranosyl) ethanoic acid 93 in 
good yield. [40] 
The three synthons were then used to prepare the final products. 
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Chapter 4. Preparation of final products modified at position 1 
4.1	 Synthesis of a senes of products modified at position 1 ­
C-mannosides (series 1) 
A series of C-mannosides were first prepared. 
Scheme 24: target compound of series 1 
o 'l~:N 
N 
I 
R1 
Schema 35: synthesis of a series of products modified at position 1 (series 1) 
AC.~OAC~O	 AcO AcO~O AcO~  BOP, DIPEA AcO	 AcO 
AcO + ~yC02Me 
C02H 
93 82 94 0 ~ 
R1N3 
Click chemistry	 Cui, DIPEA 
Toluene 
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The acid 93 was combined with methyl L-propargylglycinate 82 in the presence 
of BOP to give 94, which was then treated with a series of azides using click 
chemistry conditions to give a series of compounds 95. They were de-O-acetylated by 
the standard Zemplen method (NaOMe, MeOH), to give another series of compounds 
96, which was further saponified by solution of lithium hydroxide (LiOH) in aq. THF, 
to give the first series 97 having a free acid. The following final products were 
obtained 
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Table 5: Final produc ts mod ified at position 1 (series 1) ( following page). 
R1 R2 Yield (%) 
099 
0100 
U102 
U103 
ffHO //105 
.o:HO //106 
.x.,108 
0 
109 ~O H 
0 
111 ~O/ 
0 
112 ~OH 
0 
114 ~O/ 
0 
115 ~O H 
117 »<:> 
118 »<:> 
~OHMe0 2C 119 
Me 
H 
Me 
H 
Me 
H 
Me 
Me
 
Me
 
H 
Me 
H 
Me 
H 
Me 
81 
94 
73 
95 
43 
quant 
31 
41 
88 
quan t 
74 
quant 
75 
91 
7 
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4.2 Syntheses	 of another senes of products modified at position 1 
C-mannosides (series 2) 
To determine better inhibitors, another series of compounds, modified at position 
1 by replacing propargylglycine with propargylamine, were synthesized. 
Scheme 36: target compounds of series 2 
R
, 
H	 rrN, N~~"N( N 
o 
By retrosynthesis analysis, this compound can be decomposed in three parts: 
azide, propargylamine, and the sugar acid. The synthesis of the azide and the acid 
are described above, propargylamine is a commercial product, so the three synthons 
could be combined together. 
Scheme 37: syntheses of another series of products modified at position 1 
(series 2) 
AC~OAcO
-0
 
A),9,O
 
BOP,DIPEA
 
DCM,67%

93 C02H 
o 
RN	 I Click chemistry 
3 t	 43-90 % 
83-70% 
121 
R= ;= ,LQ-OH 
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The acid 93 was treated with propargylamine in the presence of BOP to provid 
propargyl amide 120, which was reacted with a series of azides using click chemistry 
conditions to give a series of compounds 121, After de-O-acetylation, a series of 
compounds 122 was obtained. So we got following two products: 
Scheme 38: final product of series 2 
r 
H I \
-J(N N "N 
N 
o 
124 126 
4.3 Synthesis of mannoside modified at position 1 with elongated carbon 
chain 
Sheme 39: synthesis of methyl 3-(a.-D-mannopyranosyl)propanoate 129 
HBr/AcOH AcO
-0ACX1;0AcO ACX1;0AcO -0 AcO 
AcO AcO
 
OAc
 127 Br 
o 
~OMe 
Zernplen 
o .. o 
NaOMe 
OMe MeOH ~OMe 
129 128 
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2,3,4, 6-Tetra-O-acetyl-a-D-malillopyranosyl bromide 127 was prepared by the 
usual method and then treated with methyl acrylate under radical conditions to give 
methyl 3-(2', 3', 4', 6'-tetra-O-acetyl-a-D-manilopyranosyl)propanoate 128, which 
was de-O-acetylated by the standard Zernplen method to give the final product 
methyl 3-(a-D-malillopyranosyl)propanoate 129. [41] 
4.4 Synthesis of a senes of products modified at position 1 
(O-mannosides) 
To determine the best inhibitor of FimH, we have synthesized the following 
Osmannosides using cross metathese: 
Scheme 40: synthesis of O-mannoside derivatives modified at position 1 
ACO~ACC:O ACO~ACC:OAcO AcOAcO AcO ~ 
O~ Grubbs 1st generation O~ 
OCM, reflux 
130 69% 131 
Zernplen 
CH30Na/CH30H 
95% 
Ethanol 
97% 
133 132 
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Allyl 2, 3, 4, 6-tetra-O-acetyl-cx-D-mannopyranoside 130 was treated with 
styrene by cross metathese catalyst (Grubbs first generation), to give 3' -phenylallyl 2 , 
3, 4, 6-tetra-O-acetyl-cx-D-mannopyranoside 131. After de-O-acetylation by the 
standard Zemplen method, 3' -phenylallyl cx-D-mannopyranoside 132 was obtained. 
This compound was reduced by hydrogen catalyzed by palladium and 
3' -phenylpropyl cx-D-mannopyranoside 133 was obtained in very good yield (97%) . 
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Chapter 5 Synthesis of mannoside derivatives modified at position 6 
To determine potentially better inhibitors, several other mannoside derivatives 
modified at position 6 were synthesized 
Phe142 
W1 
Asp47 
Asp140 
Asn46 
AspS 
Asn135 
Modifications at position 6 
Figure 8: Interaction between the groups at position 6 of mannoside and aminoazid residues 
ofFimH 
In this figure , oxygen at position 6 forms several hydrogen bridges with acidic 
FimH residues; therefore, we decided to replace the oxygen atom with other groups to 
increase potential binding interactions between them. 
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Scheme 41: retrosynthetic analysis of a-D-mannopyranoside derivatives at 
position 6 
H~OHH~O ~O RhII OMe N 'N~~~~\
 
il H~O~ Jl
 
/' OMe R N~~'6,~~'6, ~ H~O-0 
H~O~ ~ OMe(R) 
OMe~ H2~~~\ H~o~ ~R'HN 
OMe(R) HO~~~\ 
HO~ 
OMe(R) 
First, the hydroxyl group at position 6 of methyl a-D-mannopyranoside was 
transformed into an azide which was then converted to a triazole by click chemistry 
or reduced to an amine, and the amine can be further transformed into an amide or a 
secondany amine 
5.1 Preparation of azide at position 6 
Scheme 42: methyl 6-azido-6-deoxy-a-D-mannopyranoside 
TsCI, Pyridine H,~OHO-0 TS~~O\ NaN3 • DMF NXl;HOH~O 72% H\10-0 63% H~O -0 
OMe OMe OMe 
13583 134 
53 
Methy l a -D-mannopyranoside 83 was actived by TsCI in pyridineJ42 j The 
resulti ng 6-0 -tosy late was then displaced by NaN3 in DMF to provide the known 
meth yI6-azido-6-deoxy-a-D-mannopyranoside 135 in good yield. 
5.2 Preparation of amine at position 6 
Scheme 43: synthesis of methyl 6-amino-6-deoxy-a-D-mannopyranoside 
N~OH-0 H2~1\lOH
-0H~O H~OMeOH ,71 % 
OMe OMe 
135 136 
Methyl 6-azido-6-deoxy-a-D-m annopyranosid e 135 was reduce d by 
hydrogenation in the presence of 10% palladium on carbon (Pd/C) in methanol, to 
afford known methyl 6-amin-6-deoxy-a -D-maru10pyranoside 136 with good yield. 
5.3 Preparation of triazole at position 6 
Scheme 44: synthesis of triazole 138 
HO N':::-N ~Xl;NN~ACO
- 0 AcO-0 
AcO AcO 
AcO AcOCul,DIPEA 
TolueneOMe OMe 
20% 
137 138 
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Methyl 2, 3, 4-0-triacetyl-6-azido-6-deoxy-a-D-mannopyranoside 137 was 
treated with propargyl alcohol under click chemistry conditions (catalyzed by CuI), to 
give the corresponding triazole 138 in low yield (20%). To increase the yield, we 
changed the strategy; we used propargyl acetate instead of prop argyl alcohol. The 
reaction is as follow: 
Scheme 45: synthesis of 140 
AcO N':::-N N~ACO
-0AcO AcO
-0AcO ~~NAcO
OMe Cui, DIPEA 
AcO 
Toluene OMe57% 
137 139 
55% 
140 
Propargyl acetate reacted with methyl 2,3,4-tri-O-triacetyl-6-azido-6-deoxy-a­
D-mannopyranoside 137 under the same click chemistry conditions (catalyzed by 
CuI) , to give the corresponding triazole 139 with increased yield (57%). After 
de-O-acetylation, the final product 140 was obtained in a moderate yield. 
Finally, we synthesized other triazoles: 
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Scheme 46: synthesis of 143 
ACX::E;0OAc
-0 
AcO 
AcO 
N~OAC
-0 
ACX::E;0OAc
-0AcO 
AcO 
0,--= 
AcO 
AcO 
137 
Cul ,DIPEA 
OMe 
N<'N-X::E;NOAc
-0 
AcO 
AcO 
141 Toluene, 60% 142 OMe 
H~OH
-0 H~O 
N<'N-X:1;NHO
-078% H~O 
OMe 
143 
Methyl 2,3,4-tri-O-acetyl-6-azido-6-deoxy-a-D-mannopyranoside 137 reacted 
with prop argyl 2,3,4,6-tetra-O-acetyl-a-D-mannopyranoside 141 under click 
chemistry conditions to give the corresponding triazole 142 in 60% yield. After 
de-O-acetylation, the final product 143 was obtained with 78% yield. 
BIOLOGICAL TEST 
The relative binding ability of the mannosides was evaluated by surface plasmon 
resonance (SPR) measurements on a Biacore3000TM. The affinity of the lectin domain 
of isolated FimH of E. coli toward our mannosides was obtained by competition between an 
immobilized anti-FimH antibody (1C10) and free mannosides (Table 6). 
Surface Plasmon Resonance measurements on a Biacore3000™ 
Expression and Purification 
Bacteria were grown in minimal medium containing 40 p,g/ml of all the amino 
acids, 0.4% glucose, 2 p,glml biotine, 2 p,glml thiamine, 2 mM MgCh and 25 p,glml 
kanamycine at 37 °C. At OD6oonm = 0.6 the C43 (DE3) cells were induced with 1 mM 
IPTG. After over night incubation at 37 °C, cells were collected and the periplasmic 
content was extracted. The lectin domain ofFimH was purified by dialysing for 4 h at 
4 °C against 20 mM Na formate, pH 4, and loading it onto a Mono S column 
(Pharmacia), The protein was eluted with 20 mM Na formate, 1 M NaCI pH4 . 
Fractions containing FimH lectin domain were pooled and dialysed overnight at 4°C 
against 20 mM Hepes, 150 mM NaCI pH 8. 
Immobilization ofFab fragments of the monoclonal antibody lClO 
Affinity measurements usin g SPR was performed basically as described in 
materials and methods in Bouckaert et al. (2005). All SPR measurements were 
performed on a Biacore3000 .™ A monoclonal antibody 1Cl 0 against the mannose­
binding pocket of FimH was produced by a mouse hybridoma cell line at 
Medimmune and its Fab fragments were purified. We used these Fab fragments to 
determine the solution affinity of the lectin domain of FimH for different mannose 
derivati ves . The surface of flow cell 2 (Fc2) was activated with 35 p,1 of EDCINHS 
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[mixture ofEDC (200 mM) and NHS (50 mM)]. lClO Fabs dissolved at 100 ug/rnl in 
10 mM sodium acetate buffer pH 5 was subsequently covalently coupled as ligands 
onto a CM5 biosensor chip (BIAapplications Handbook, Biacore AB, Uppsala, 
Sweden) at 530 RU (resonance units = pg ligand per mrn") in Fc2 via free amine 
groups. The excess of succinimide esters on the surface of the chip were deactivated 
by the injection of 35 ILl of 1 M ethanolamine at pH 8.5. Fcl was activated and 
deactivated the same way as Fc2, but without Fab immobilisation, and was used as 
the reference cell. 
Determination of the affinity of FimH for the immobilized Fab fragments 
The kinetic constants for binding of the lectin domain of FimH to the immobilized 
lClO antibody were measured by flowing a two-fold serial dilution ofFimH, ranging 
from 2000 nM down to 1.95 nM in running buffer [20 mM Hepes pH 7.4, 150 mM 
NaCI, 0.005% surfactant P20 and 3 mM EDTAJ, sequentially over Fcl and Fc2, at 
298 K. The evolution of the optical signal from Fc2 minus Fcl, measured in Rus, 
was followed in time. The flow rate was 20 fll per min, the association time 4.5 
minutes. The dissociation was allowed to proceed for 25 minutes, by injecting only 
running buffer, to completely dissociate FimH from the 1Cl 0 antibody before starting 
another binding cycle. Zero concentration data was obtained by injecting only running 
buffer over the sensor chip. The binding of FimH to lClO was evaluated using the 
BIAevaluation software version 4.1. A Langmuir binding isotherm with a 1:1 stoichiometry 
was fitted simultaneously to the association and dissociation phases, to obtain in global 
reaction rate constants k, and kJ and the maximum analyte binding response Rmax. 
Affinity measurements and fittings 
The affinity of the lectin domain of FirnH for different mannose derivatives was obtained 
by competition between antibody and sugar for the FirnH lectin domain. Each mannose 
derivative was diluted at least 11 times in a two-fold serial dilution. To each of the sugar 
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concentrations, including a zeroconcentration, a concentration of the lectin domain ofFimH 
wasadded thatwas close to the dissociation constant at equilibrium K, of the Fiml-I-antibody 
interaction, calculated from the foregoing experiment. Analyses of all binding cycles were 
again performed using the BIAevaluation software version 4.1. The concentrations of FimH 
lectin domain free from sugar and thus able to interact with the inunobilised 1C1 0 antibody 
were obtained by fitting a Langmuir binding isotherm with 1:1 stoichiometry to the data, 
using the global parameters ka, k(J and Rmax from the former experiment. These FimH 
concentrations were plotted as a function of the sugar concentrations. Fitting using the 
solution affinity interaction model (B-A-~) /2+(O .25 *(A+B+I~ i -A*B)O.5, where A is the 
sugarconcentration, B is theinitial fixed concentration of the lectin domain ofFimH added to 
each sugarconcentration delivered Kd' the dissociation constant at equilibrium or the affinity 
ofFimH for the sugar. 
CONCLUSIONS AND PERSPECTIVE 
After biological testin g, the following results were obtained: 
Table 6: The results of biological test (in structure) 
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Table 7: The results of biological test (in table) 
Product name Kd [nM]
 
Man 2300
 
MeMan 1430
 
103 1661
 
112 5360
 
115 4180
 
118 1610
 
126 1130
 
132 53.2
 
133 59.3
 
136 No activity
 
140 70800
 
Graphic 1: The results of biological test 
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Scheme 46: The less active product 112 and the most active produt 132 
9' 10' 
2' HN 3' CO H H~~o\'-.../" 2 H~O~~,5' s17' 
o	 ,c-; :::::,... 
" 6'l' 3' 4' 5' 
112 132 
Kd(nM):5360	 Kd(nM):53.2 
112 has two terminal hydrophilic groups and no hydrophobic groups, it has 
less activity: 132 has one hydrophobic group, it hasn't any terminal hydrophilic 
groups (except the sugar part), it has the most activity, 
From the above results, one can get following conclusions: 
A:	 The compounds modified at position 6 (compounds 136 and 140) are far less 
active than the compounds modified at position 1 (anomeric position); 
B:	 All C-mannosides are less active than O-mannosides; 
C:	 For C-mannosides modified at the anomeric position, 126 is less complex 
than 103, 112,115, 118 and it is more active than them; 
D:	 For compounds 103, 112, 115, 118, they can be divided in two groups: 103 
and 118 have one terminal free acid group and one hydrophobic group 
respectively, and 112 and 115 have two terminal acid groups . 103 and 118 are 
more active than 112 and 115; 
E:	 For 103 and 118, the 103 has one terminal aromatic group, 118 has one 
terminal aliphatic group, and their activity are nearly the same; 
F:	 132 and 133 are O-mannosides, their activi ties are nearly the same, there into 
132 is an unsaturated derivative and 133 is a saturated derivative, 132 is 
slightly more active than 133. 
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For future work, one should synthes ize mannosides inhibitor according to 
following principles: 
A.	 Mod ifiy at the anomeric position ; 
B.	 If possible, synthes ize O-mannopyra nos ide; 
C.	 If C-mannopyranos ide must be synthes ized, molecul e structure simi lar to 126 
is the priority choice; 
D.	 Increase the number of terminal hydrophobic groups and redu ce the number 
of terminal hydrophilic groups. 
CLAIMS 
The first step of looking for a medication is decision of therapeutic target. 
The works of professor Henri De Greve tell us that FimH adhesin located at the 
tips of type 1 pili are important virulence factors for the establishment of 
Escherichia coli urinary tract infections (UTIs) which is the most common cause 
of infections both in the urethra (urethritis) and the bladder (cystitis) in the lower 
urinary tract, as well as the more severe infections in the kidneys (pyelonephritis) 
that can develop if the infection is not treated in time. Blocking of bacterial 
adhesion is able to prevent infection. Professor Henri De Greve and co-workers 
provided for the first time, binding data of the molecular events underlying type I 
fimbria I adherence, by crystallographic analyses of the FimH receptor binding 
domains, and affinity measurements with mannose, and a series of alkyl and aryl 
mannosides. 
Butyl c-D-mannopyranoside, bound in the crystal structures, exhibits a 
significantly better affinity for FimH (Kd = 0.15 mM) than mannose (Kd = 2.3 
mM). Exploration of the binding affinities of a-D-mannopyranoside with longer 
alkyl tails revealed affinities up to 5 nM. In the chemical part, we have 
synthesized several series of mannopyrannosides modified at either the anomeric 
position or position 6 using 'Click Chemistry' , Cross meta these, Sakurai type 
reaction, Diazotransfer reaction and Radical reaction. For mannopyranosides 
modified at the anomeric position, we have synthesized two series of compounds; 
O-mannopyranoside and C-mannopyranoside to compare their affinity. 
The relative binding ability of the mannopyranosides was evaluated by 
surface plasmon resonance (SPR) measurements. The results of biological testing 
told us that: 
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A. Mannopyranosides modified at position 6 are far less active than 
mannopyranosides modified at the anomeric position; 
B.	 All O-mannopyranosides are more active than C-mannopyranosides; 
C.	 Mannopyranosides which have terminal hydrophobic groups are more active 
than mannopyranosides which have terminal hydrophilic groups. 
D.	 Mannopyranosides which have unsaturated groups have nearly the same 
activity as mannopyranosides which have saturated groups. 
The result of present work has been published in 3 journals. See page 131. 
EXPERIMENTAL PART
 
General methods: 
Flash chromatography was performed using Merck silica gel 60 
(0.04020.063 mm, 2302400 mesh). TLC was performed on Kieselgel 60 F254 
plates from Merck. Detection was carried out under UV light or by spraying with 
20% ethanolic sulfuric acid or ammonium molybdate solution [50 g 
(NH4)6M07024.4H20, 12.2 g Ce(S04)2, 200 ml concentrated H2S04, 1.8 L distilled 
water] followed by heating. Tetrahydrofuran was distilled on sodium prior to use. 
Infrared spectra were recorded on a Perkin-Elmer 1600 (KBr) FTIR 
instrument. NMR spectra were measured with a Varian 300 (300 MHz for IH 
and 75 MHz for l3C NMR) spectrometer. Chemical shifts are in ppm, relative to 
internal TMS (8 == 0.00 for IH and 13C NMR) or solvent peaks, which were 
calibrated as follows: CDC I) (8 == 7.27 for IH and 8 == 77.0 for l3C NMR), [d4] 
methanol (8 == 3.30 for IH and 0 == 49 .0 for l3C NMR). Where necessary, DEPT, 
APT, and two-dimensional IH_I H COSY experiments were performed for 
complete signal assignments. Optical rotation values were obtained using a 
JASCO P-1000 Polarimeter (Na-D line, 589 nm, cell length 5 ern), ESI-MS 
anal yses were carried out on a MICROMASS Quattro LC instrument at the 
University of Montreal. 
I Preparation of azides 
The structures of all azides were confirmed by IR and displayed a strong, 
sharp band between 2100-2095 cm- 1 for the azide stretching band and these were 
used without further purification except were indicated. 
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1.1 Preparation of azides from halides 
RX 
Methyl Azide 
Methyl iodide (0.62 ml , 10 mmol) was heated at 55°C overnight in 6.2 ml 
DMF containing 1.5 ml of water and sodium azide (0.77 g, 11 .8 mmol). The 
product was distilled out of the reaction mixture to give 88 mg of methyl azide [31]. 
(in toluene) 
Yield: 15% 
'H NMR (300 MHz, CDCb): 83.01 (3 H, s, CH3) 
Ethyl azide 
Eth yl bromide (0.75 ml, 10 mmol) was refluxed overnight in 6.2 ml DMF 
containing 1.54 ml of water and sodium azide (0.77 g, 11.8 mmol) . The product 
was distilled out of the reaction mixture and dried over sodium sulfate to give 520 
mg of ethyl azide. [31] 
Yield : 73% 
'n NMR (300 MHz, CDCb): 8 3.45-3.35 (2 H, q, J = 7.40 Hz, CH2) , 1.30-1.24 
(3 H, t, J = 7.28 Hz , CH3) 
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Propyl Azide 
~N3 
Same procedure as for the preparation of ethyl azide . 
Yield : 91% 
I H NMR (300 MHz, CDCh): 03.29-3 .21 (2 H, t, J'= 6.87 Hz, CH2NJ), 1.70-1.58 
(2 H, m, CHJCfu), 1.04-0.95 (3 H, t, J'= 7.29 Hz, CHJ). 
Isopropyl Azide 
Same procedure as for the preparation of ethyl azide. 
Yield : 88% 
I H NMR (300 MHz, CDCh): 03.69-3.56 (1 H, m, CH), 1.27-1.22 (6 H, d, J '= 
6.32 Hz, 2 x CHJ). 
Allyl Azide 
~N3 
Same procedure as for the preparation of ethyl azide . 
Yield: 93% 
I H NMR (300 MHz, CDCb): 0 5.97-5 .81 (l H, m, CH2'=CH), 5.38-5 .28 (2 H, m, 
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Cfu==CH), 3.82-3 .75 (2 H, d, J== 6.04 Hz, CfuN3) 
Tert-butyl azide 
Same procedure as for the preparation of ethyl azide. 
Yield: 93% 
IH NMR (300 MHz, CDCh): (3 1.28 (9 H, s, 3 X CH 3) . 
Cyclopentyl azide 
Cyclopentane bromide (1.07 mI, 10 mmoI) was refluxed overnight in 4 mI of 
water containing Bu4NBr (0.326 g, 1.0 mmol) and sodium azide (1.307 g, 20 
mmoI). The product was extracted with EhO, dried over sodium sulfate; solvent 
was evaporated under reduced pressure slowly to give 4.86 g of cyclopentyl azide . 
Yield: 80% 
IH NMR (300 MHz, CDCh): 83.99-3.90 (I H, m, CH), 1.85-1.50 (8 H, m, 4 x 
CH2). 
l3C NMR (75 MHz, CDCh): 8 62.7 (C-I), 3].8 (C-2, C-5), 23.2 (C-3, C-4) . 
Cyclohexyl azide 
69 
N3 
2~6 
3V 5 
4 
Same procedure as for the preparation of cyclopentyl azide . 
Yield: 75% 
'n NMR (300 MHz, CDCh): 8 1.60-1.40 (11 H, m). 
l3C NMR (75 MHz, CDCh): 8 59.8 (C-l), 31.5 (C-2, C-6), 25.2 (C-4), 24.1 (C-3, 
C-5) . 
Benzyl azide 
Benzyl bromide (1.19 ml, 10 mmol) was dissolved in water (4 ml) and Et20 
(4 ml), sodium azide (1.3 g, 20 mmol) and Bu4NHS04 (0.34 g, 1.0 mmol) were 
added successively, the mixture was stirred at room temperature for one day. The 
two phases were then separated, and the aqueous phase was extracted with Et20, 
while the combined organic phases were dried over sodium sulfate and evaporated 
under reduced pressure to afford 1.428 g of product. 
Yield : quantitative. 
IH NMR (300 MHz, CDCI3) : 87.46-7.30 (5 H, m, Haromatique), 4.38 (2 H, s, CH2). 
Tert-butyl 2-azidoacetate 
70 
Same procedure as for the preparation of benzyl azide. 
Yield: 92%. 
IH NMR (300 MHz, CDCI3) : 83 .78 (2 H, s, CH2), 1.51 (9 H, s, 3 x CHJ). 
Methyl 3-azidopropionate 
. Same procedure as for the preparation of benzyl azide. 
Yield : 61%. 
IH NMR (300 MHz, CDCh): 83.73 (3 H, s, CHJ), 3.61-3 .56 (2 H, t,J= 6.32 Hz, 
COCH2), 2.61-2.57 (2 H, t, J = 6.32 Hz, CH2NJ). 
I3C NMR (75 MHz, CDCh): 8 171.3 (C=O), 51.9 (CHJ), 46 .7 (CH2NJ), 33.7 
(~H2CO). 
Ethyl 2-azidoacetate 
Same procedure as for the preparation of benzyl azide. 
Yield: quantitative. 
IH NMR (300 MHz, CDCh): 84.31-4 .23 (2 H, q, J= 7.14 Hz, ClliCHJ), 3.87 (2 
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H, s, CHzN3), 1.34- 1.30 (3 H, t, J = 7.14 Hz, CHzCH3).
 
13C NMR (75 MHz, CDCh): 8 168.3 (C=O), 6 1.8 (.GHzCH3), 50.3 (CHzN3),
 
14.1 (CHz.GH3). 
1.2 From amines and amino ac ids 
First, the triflyl az ide reagent was prepared by the following method (TfN3) 
H20,CH2CI2
 
O°C,2h
 
Sodium az ide (1.78 g, 27.38 mmol) was diss olved in distilled water (4.5 ml) 
with DC M (7.5 ml) and cooled on an ice bath . TfzO (0.93 ml , 5.53 mmol) was 
added slow ly ove r 5 min with stirring was continued for 2 hrs. The mixture was 
then placed in a separatory funnel and the organic phase removed. The aqueo us 
phase was extracted with DCM (2 x 3.75 ml). The orga nic fractions were pooled 
and was hed once with saturated sodium sulfa te (5 ml) and used without furth er 
purification. [32] 
The follow ing azides were then prepared by the diazotransfert reaction using 
the crude triflyl azide . [32] 
1.5 K2C03, 1% CUS04 
H20. CH30H. CH2CI2 
Azido tyramine 
72 
541 
~N3 
HO~2 
5 4 
Tyramine (138 mg, 1.0 mmol) was combined with K2C03 (207 mg, 1.5 
mmol), CuS04.5H20 (2.5 mg, 0.0 1 mmol), distill ed wa ter (3.2 ml) and CH30 H 
(6.5 ml ). TfN 3(6.7 ml, 1.85 mm ol) was added and the mixture was stirred at room 
temperature overnight. The mixture was then separated, and the aqueo us portion 
was extracted with DCM, while the combined organic portions we re evaporated 
under redu ced pressure. The residu e was purifi ed by flash chr omatography on 
silica ge l (E tOAc /Hexa ne= 20%) to afford azido tyramine (142 mg). [32] 
Yield : 87%. 
IH NMR (300 MHz, CDCI3): (37.07 -7.04 (2 H, dd, J = 2.22, 6.32 Hz, H-4), 
6.77-6 .74 (2 H, dd, J = 2.22,6.32 Hz, H-5), 3.45-3.40 (2 H, t, J = 7.14 Hz, H-2), 
2.82-2.76 (2 H, t, J = 7.14 Hz, H-l). 
13 C NMR (75 MHz, CDCh): (3 154.0 (C-6), 130.0 (C-3), 129 .8(2 x C-4), 11 5.4 (2 
x C-5), 52.4 (C- l), 34. 1 (C-2). 
Azido-L-pbenylalanine 
L-phenylalanine (166 mg, 1.0 mm ol) was combined with K2C03 (207 mg, 
1.5 mmol), CuS 04 .5H20 (2.5 mg, 0.0 1 mmol), distilled water (3.2 ml) and 
CH30 H (6.5 ml) . TfN3(6.7 ml, 1.85 mmol) was added and the mixture was stirred 
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at room temperature overnight. The organic solvents were then removed under 
reduced pressure and aqueou s slurry was diluted with water (18 ml). This was 
acidified to pH 6 with concentrated Hel, diluted with phosphate buffer (18 ml, pH 
6.2) and extracted with EtOAc (4 x 12 ml). The aqueous phase was then acidified 
to pH 2 with concentrated Hel, extracted with EtOAc (3 x 12 ml) , dried with 
sodium sulfate and evaporated to dryness (171 mg) , 
Yield : 85%. 
IH NMR (300 MHz, CDC!)): 87.40-7.20 (5 H, m, Haromatic), 4 .19-4 .10 (I H, dd, 
J= 5,09,8.93 Hz, Ha-2), 3.27-3 .20 (I H, dd, J= 4.95,14.01 Hz , H-I), 3.04-2.98 
(I H, dd, J= 8.79,14.01 Hz, Hb-2). 
Azido-D-phenylalanine 
Same procedure as for preparation ofAzido-L-phenylalanine. 
Yield : 90% . 
IH NMR (300 MHz, CDC!)): 87.38-7.20 (5 H, ill, Haromatic), 4.15-4 .07 (1 H, dd, 
J= 9.07,14.01 Hz, Ha-2), 3.25-3 .15 (I H, dd, J= 4.94,14.01 Hz, H-I), 3.04-2.95 
(I H, dd, J = 4,94, 8.79 Hz, Hb-2). 
Azido-L-serine 
74 
Same procedure as for the preparation of azido-L-phenylalanine. 
Yield : 37%. 
'n NMR (300 MHz, CD30D): 84.02-3 .97 (I H, t, J= 4.4 Hz, CH) , 3.80-3 .77 (2 
H, d, J = 4.39 Hz, CHz). 
Azido-D-serine 
Same procedure as for preparation of azido-L-phenylalanine. 
Yield: 66%. 
IH NMR (300 MHz, CD30D): 84.03-3.96 (1 H, t, J = 4.12 Hz , CH) , 3.90-3.86 
(2 H, d, J = 4.4 Hz, CHz). 
Azido-methyl L-serine 
Methyl L-serine (156 mg, 1.0 mmol) was combined with KZC03 (207 mg, 
1.5 mmol), CuS0 4.5HzO (2.5 mg, 0.01 mmol), distilled water (3.2 ml) and 
CH30 H (6.5 ml) . TfN3(7.2 ml , 2.0 mmol) was added and the mixture was stirred 
at room temperature overnight. Two phases were then separated and the aqueous 
portion was extracted with DCM (3 x 10 ml), while the combined organic portions 
were dried with sodium sulfate and purified by flash chromatography on silica gel 
75 
(EtOAc/Hex ane = 50%) to afford Azid o-methyl L-serine (124 mg).
 
Yield: 86%.
 
1H NMR (300 MHz, CDCl3) : 8 4.06-4.09 (I H, t, J> 4.72 Hz, CH), 3.88-3.90 (2
 
H, d, j= 4.67 Hz, CHz), 3.80 (3 H, S, CH3) .
 
Azido-L-Asparagine 
Same procedure as for the prep aration of Azido-L-phenylalan ine. 
Yield: 48%. 
1H NMR (300 MHz, CD30D): 8 4.43-4.37 (I H, dd, J = 4.67, 8.51 Hz, H-I), 
2.78-2.72 ( I H, dd, J = 4.67 , 15.66 Hz, Ha-2), 2.62-2.55 ( I H, dd, j = 8.51, 15.66 
Hz, Hb-2). 
Azido-L-Threonine 
Same procedure as for the prep aration ofAzido-L-phenylalanine. 
Yield: 47%. 
1H NMR (300 MHz, CDCh): 8 4.42-4.38 ( I H, m, H-2), 3.95-3.92 ( I H, d, J = 
2.74 Hz, H-I ), 1.40-1.38 (3 H, d, J= 6.60 Hz, CH3) .
 
i3C NMR (75 MHz, CDCl 3) : 0 173.0 (C=O), 68.6 (C-I) , 66.7 (C-2), 19.6 (CH3) .
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Azido-L- Tyrosine 
Same proce dure for the preparation of azido-L-phenylalanine. 
Yield: 47%. 
IH NMR (300 MHz, DMSO): 87.05-7.00 (2 H, d, J = 8.52 Hz, H-4), 6.69 -6.65 
(2 H, d, J = 8.51 Hz, H-5), 4.10-4 .01 (1 H, dd, J = 4.67,9.06 Hz, H-I), 3.00-2.95 
(1 H, dd,J = 4.81,14.14 Hz, Ha-2), 2.80-2.74 (1 H, dd,J= 8.93,14.14 Hz, Hb-2) , 
Be NMR (75 MHz, DMSO): 8 171.8 (C=O), 156.1 (C-6), 130.1 (C-3), 127.2 
(C-4), 115.1 (C-5), 63 .4 (C- l), 36.2 (C-2). 
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II L-Propargylglycine methyl ester hydrochloride 
II-I Diethyl a-acetamido-a-propargylmalonate 77 
Sodium (1.68 g, 40 mmol) was dissolved in 40 ml of abs. ethanol under 
nitrogen. To this clear solution, 13.88 g (64 mmol) of diethyl 
cc-acetamidomalonate, dissolved in 80 ml of abs . ethanol, was added dropwise. 
The temperature was raised to 60°C. After 6 h, the solvent was evaporated and the 
oily residue was treated with dry acetonitrile, and a solid was obtained. The solid 
residue (64 mmol) was dissolved in 60 ml of DMF and treated with 8.69 g (71 
mmol) of propargyl bromide (stirring at 80 °C under N2). The temperature was 
raised to 120°C and stirring continued for 3 h. After cooling, the precipitated 
NaBr was removed by filtration, the solvent evaporated, and the residue dissolved 
in water and ether. The organic phase was washed twice time with water, dried, 
and evaporated. The residue crystal1ized from isopropyl alcohol /petroleum ether 
to give 77 (7.79 g). [34] 
Yield: 48%
 
IH NMR (300 MHz, CDCI3) : 8 6.95 (1 H, s, NH), 4.30 (4 H, q, J = 7.14 Hz,
 
OCH2), 3.28 (2 H, d, J =: 2.47 Hz, ClhCCH), 2.07 (3 H, S, CH 3CO), 1.98 (I H, t, J
 
= 2.47 Hz, CH2CCH), 1.27 (6 H, t, J = 7.14 Hz, OCH2CH3).
 
DC NMR (75 MHz, CDCh): 8 169.2, 166.6,78.2,71.3,65.2,62.9,23 .8,22.9,
 
13.9 . 
11.2 Monoethyl a-acetamido-a-propargylma1onate 78 
78 
A solution of KOH (2 .24 g, 40 mmol) in 5.5 ml of water and 84.5 ml of 
ethanol was slowly added to a solution of diethyl 
c-acetamido-c-propargylrnalonate (6.8 g, 26.6 mmol) in 44 ml of ethanol. The 
resulting solution, 0.3 M with respect to KOH, was kept for 3 h at 20 °e. Excess 
alkali was neutralized with 6.7 ml2 N HCI; after 15 h at 4°C KCI was removed by 
filtration and the filtrate evaporated. The residue was dissolved in 83.4 ml of 
water at O°C, acidified to pH 2 with 2 N HCI, and the precipitate gathered , washed, 
and dried to give product 78 (5.14 g). [34] 
Yield : 85% 
'n NMR (300 MHz, CD3COCD3 ) : 87 .68 (1 H, s, NH), 4.22 (2 H, q, J=7.14 Hz, 
OOC1:hCH3) , 3.23 (2 H, s, CfuCCH), 2.47 (1 H, s , CCH), 2 .06 (3 H, s, COCH3) , 
1.22 (3 H, t, J =7.14 Hz, OOCH2CH3) . 
11.3 Ethyl D, L-N-acetyl-propargylglycinate 79 
The solution of monoethyl c-acetamido-c-propargylrnalonate (4 .72 g, 20 . 8 
mmol) in 49 ml of dioxane was boiled for 24 h (bath temp. l30°C). The solvent 
was evaporated and the residue was purified by flash chromatography on silica gel 
79 
(MeOH/CH 2CIz = 5%) to afford ethyl D, L-N-acetyl-propargylglycinate 3.11 g. [34] 
Yield : 81%
 
I H NMR (300 MHz, CDCh): 86.33 (I H, bs , NH), 4.73 (I H, m, NHCH), 4.25
 
(2 H, m, J = 7.15 Hz, CH 2CH3) , 2 .79 (2 H, m, J = 2,61 Hz, CfuCCH) , 2.07 (3 H,
 
s, COCH3) , 2.03 (1 H, t, J = 2,61 Hz, CCH), 1.31 (3 H, t, J = 7.15 Hz, CH2CH3) .
 
l3 C NMR (75 MHz, CDCh): 8 170.3, 169.7,78.5,71.5, 62 .0, 50.6,23.2,22.5,
 
14.1. 
11.4 CD, L)-N-Acetyl-propargylglycine 80 
Ethyl D, L-N-acetyl-propargylglycinate (0.312 g, 1.7 mmol) was dis solved in 
3 ml of ethanol and hydrolyzed for IS h at 20°C with 0.112 g (2 mmol) of KOH in 
0.25 ml of water and 2.5 ml of ethanol. The ethanol was then evaporated, and the
 
residue acidified to pH 2 with 1 N HC!. The product was extracted with ethyl
 
acetate and dried by vacuum pump. 0.209 g of D, L-N-Acetyl-propargylglycine
 
wa s obtained. [34]
 
Yield : 86%
 
'H NMR (300 MHz, DMSO).: 8 8.28 (1 H, bs, NH) , 4.30 (1 H, m, NHCH), 2.88
 
(1 H, t, J = 2.75 Hz, CCH), 2.55 (2 H, m, CfuCCH), 1.81 (3H, S, CH3CO).
 
n.s L-Propargylglycine 81 
80 
D, L-N-Acetyl-propargylglycine (0.204 g, 1.31 mmol) was dissolved in 
water (13 ml). After adjustment of the pH to 7.5 with ammonia, 1 mg of porcine 
renal acylase I (Sigma-Aldrich) and 1.56 mg CoS04.7I-hO were added. After 15 h 
at 37°C more acylase (1 mg) was added, and the hydrolysis was continued for 4 h. 
The reaction was stopped, and the acylase denatured by the addition of 0.1 ml of 
trifluoroacetic acid and heating at 50°C for 10 min . The solution was cleared with 
charcoal, and its pH was adjusted to 7 with ammoni a. Most of the solvent was 
evaporated, the residue treated with 42 mg of precipitate was obtained. [34] 
Yield : 57% 
[a]loD -31.0; Literature: [a] loD -35 .0. 
IH NMR (300 MHz, DzOl: 8 3.76 (1 H, t, J = 5.36 Hz, NH1CH), 2.71 (2 H, bs, 
CH1CCH) , 2.38 (lH, s, CCH). 
II-6 L-Propargylglycine methyl ester hydrochloride 82 
L-propargylglycine (0.182 g, 1.61 mmol) was stirred in MeOH (4 ml) , SOCIz 
(0.2 ml, 2 .7 mmol) was added, the mixture was stirred for several hours at room 
temperature then concentrated under reduced pressure to give methyl-L-propargyl 
glycinate which was used as a crude product without further purification. 
81 
III Preparation of2-(tetra-O-acety1-a-D-mannopyranosy1) 
ethanoic acid and intermediary product 94 
III. I Methyl 2, 3, 4, 6-tetra-O-benzyl-a-D-mannopyranoside 84 
BnXl;0BnO 
B 0 -0 ~nO 
OMe 
NaH (8.25 g, 200 mmol) in 50 ml DMF was stirred at 0 °C. Methyl 
Ct.-D-mannopyranoside (5.01 g, 25.8 mmol) in 60 ml DMF was added by nozzle. 
After 2 h TBAI (0.949 g, 2.58 mmol) and BnBr (23.7 ml, 200 mmol) were added 
and the mixture was stirred overnight. Excess NaH was decomposed with MeOH 
(10 ml) and water (350 ml), and the mixture was extracted with EtOAc, washed 
with water, dried with NaS04 and concentrated under reduced pressure. The 
residue was eluted from a column of silica gel with EtOAc/Hexane (15%) to give 
84 (l1 .50g) as a colorless oil. Spectroscopie data corresponded well with those of 
the literature. [35) 
Yield : 80% 
Rf: 0.50 (Hexane : EtOAc 7 : 3) 
'H NMR (300 MHz, CDCh): (5 7.40 (20 H, m, 4 x C6H5), 5.00 (I H, m, H-1), 
4 .90-4 .58 (8 H, m, 4 x PhCH 2) , 4.05 (I H, m), 3.98 (I H, m), 3.85 (4 H, m), 3.41 
(3 H, S, CH 3). 
III.2 3-(Tetra-O-benzyl-a-D-mannoppyranosyl)-I-propene 85 
82 
Bn~oBnO
-0 
BIlO sno 
/.? 
Compound 84 (9.3 g, 16.8 mmol) in CH 3CN (25 ml) was stirred at 0 °C, 
TMSAllyl (7.2 ml, 45 mmol) was added, after 15 minute TMSOTf (3.9 ml, 20.2 
mmol) was added dropwise, the reaction was stirred at 0 °C for 4 h and at room 
temperature for 20 h. Saturated NaHC03 solution (140 ml) was then added with 
stirring for I h. The mixture was extracted with CH 2Ch, washed with a solution of 
brine, dried with Na2S04, and concentrated under reduced pressure. The residue 
was eluted from a column of silica gel with EtOAc/Hexane (15%) to give 85 
(7.509 g) as colorless oil. [36]
 
Yield: 79 %
 
Rf: 0.65 (Hexane: EtOAc 7: 3)
 
'H NMR (300 MHz, CDC!]): (5 7.38-7.20 (20 H, m, 4 x C6Hs), 5.80-5.70 (1 H, m,
 
CH=CHH), 5.02 (1 H, m, CH=CHH), 5.00 (1 H, m, CH=CHH), 4.60-4.50 (8 H, m,
 
4 x PhCH2), 4.06 (1 H, m, H-l), 3.88-3.70 (5 H, m), 3.61 (1 H, dd, J= 3.02, 4.67
 
Hz), 2.35 (2 H, m,ClhCH).
 
III. 3 3-(a-D-Mannopyranosyl)-1-propene 85a 
H~OH~O HO-0 
/.? 
To a solution of85 (7.922 g, 14.0 mmol) in THF cooled to -78 °C was added 
lithium 1.0 g (144 mmol) and NH3 (liquid) was condensed until the solution had a 
persistent blue color (about 4 h). The reaction mixture was stirred for an 
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additional 2 h and then quenched with ethanol. The reaction turned a pale yellow 
and was allowed to warm to room temperature and was stirred overnight to allow 
time for the ammonia to evaporate. The remaining solution was concentrated 
under reduced pressure to dryness. 
IlIA 3-(Tetra-O-acetyl-a-D-mannoppyranosyl)-1-propene 91 
AC~OAcO~O 
AcO 
AcO 
~ 
The dried 85a was dissolved in acetic anhydride (200 m1) and pyridine (200 
m!), and catalytic DMAP (about 1 g) was added . The mixture was stirred over 
night, after which the solvent was evaporated with toluene. The crude product was 
extracted with CH2Ch, washed with brine solution (saturated) and dried with 
Na2S0 4. The residue was eluted from a column of silica gel with EtOAc/Hexane 
(15%) to give 91 (2.74 g, 7.36 mmol). [40] 
Yield: 53% 
Rf: 0.16 (Ethyl acetate: hexane 3: 7) 
'n NMR (300 MHz, CDClJ): 0 5.84-5.75 (1 H, m, CH=CH2), 5.28-5 .24 (I H, dd, 
J = 3.30 , 8.79 Hz, H-3), 5.22-5.12 (4 H, m, CH=Cfu), 4.35-4 .29 (1 H, dd, J = 
6.32, 12.09 HZ),4 .10(I H,dd,J =2.75, 12.09 Hz),4.07-4.01 (I H,m),3 .92-3 .86 
(1 H, m), 2.59-2.38 (2 H, m, CfuCH), 2.12-2.02 (12 H, m, OCOCH3). 
13C NMR (75 MHz, CDClJ): 8 171.1, 170.6, 170.3, 170.1 (O~OCH3), 132.9 
~H=CH2), 118.7 (CH=~H2), 74.5, 71.0, 70.4, 69.1,67.3,62.8, 33.9 ~H2CH), 
21.3,21.1, 21.1 (OCO~H3)' 
111.5 2-(Tetra-O-acetyl-a-D-mannopyranosyl)ethanal 92 
84 
AC~OAcO
-0 
AcO 
AcO 
CHO 
Compound 91 (2.74 g, 7.36 mmol) was dissolved in dichlomethane [40] (50 
ml), the solution was cooled to -78 °C and ozone was bubbled through the 
solution until a blue color was obtained (about 2-3 h). Nitrogen gas was then 
bubbled through the solution until it became colorless. Acetic acid (6.5 ml) was 
added to the solution at -78 °C and zinc dust (6.5 g) was slowly added to the 
vigorously stirred solution. This was allowed to come to room temperature and 
left stirring for the week end. 
The mixture was filtered over Celite and concentrated and purified by flash 
column chromatography using EtOAc/Hexane (50%) affording the purified 
compound as a colorless oil (1.31 g). [40] 
Yield: 48 % 
Rf: 0.22 (Ethyl acetate: hexan 1: 1) 
'n NMR (300 MHz, CDCh): 8 9.73-9.71 (1 H, dd, J = 1.37, 3.02 Hz, CHO), 
5.27-5.24 (1 H, dd, J = 3.30, 6.87Hz), 5.12-5.05 (2 H, m), 4.64-4.53 (2 H, m), 
4.10-4.05 (1 H, dd, J= 3.57,12.09 Hz), 3.99-3.93 (1 H, m, H-1), 2.83-2.74 (1 H, 
ddd, J = 3.02, 9.34, 16.48 Hz, CHHCHO), 2.69-2.62 (1 H, ddd, J = 1.37,4.40, 
16.48 Hz, CHHCHO), 2.13-2.09 (12 H, m, OCOCH3) .
 
l3 C NMR (75 MHz, CDCh): 8 198.7 (.GHO), 171.1, 170.2, 169.9 (O.GOCH3) ,
 
72.7,69.6,68.1,67.8,67.5,61.5,44.3 (.GH2CHO), 21.1, 21.1, 21.1, 21.1 (4 x
 
OCO.GH3) .
 
III.6 2-(Tetra-O-acetyl-a-D-mannopyranosyl) ethanoic acid 93 
85 
AC~OAcOAcO ~O 
AcO 
C02H 
Compound 92 (1.310 g, 3.50 mmol) was dissolved in tert-butanol [40] (18 ml) , 
K.H2P0 4 (1.25 M, 6.14 ml) was added and the solution was vigorously stirred. 
KMn04 (1.0 M, 7.3 ml) was added and vigorously stirred for 10 minute . Na2S03 
solution (saturated) was then added drop wise to neutralize the KMn04. The 
precipitated Mn02 was filtered, washed with 95% EtOH and the filtrate was 
concentrated under reduced pressure. CHC!) (33 ml) and saturated NaCI (13 ml) 
were added to the concentrated solution and the pH was adjusted to 3.0 with 1.0 N 
aqueous HCI solution. The acid was taken up in CHCI3 and the aqueous layer was 
extracted with CHC13 (33 ml x 2) . The combined organic extract was dried over 
Na2S04 and concentrated to afford 93 (1 .282 g); it was used directly without 
further purification. 
Yield: 94% 
Rf: 0.41 (Methanol: dichloromethane 1: 9) 
IH NMR (300 MHz, CHCI3): 8 10.12-10.18 (1 H, bs, C02H), 5.17 (I H, bs), 
5.07 (2 H, bs), 4.35 (2 H, bs), 4.09 (I H, bs), 3.92 (1 H, bs), 2.63 (2 H, bs, 
CH2C02H). 
111.7 N-(Methyl propargyl-L-glycine)-l '-(2,3,4,6-tetra-O-acetyl-a. ­
D-mannopyranosyl)acetamide 94 
86 
o	 4'~ 5'~ 
6' 
To solution of 2-(tetra-O-acetyl-a-D-mannopyranosyl) ethanoic acid 93 
(0.785 g, 2.01 mmol) in DCM (20 ml), L-methylpropargylglycine hydrochloride 
(0.403 g, 2.46 mml) and BOP( 1.08 g, 2.44 mmol) were added successively, then 
under nitrogen DIPEA (1.15 ml, 6.58 mmol) was added. The reaction was stirred 
overnight at room temperature. The mixture was then evaporated under reduced 
pressure, the residue was washed with 1 M KHS04, 1 M NaOH, and brine, dried 
with Na2S04, and purified by flash chromatography on silica gel (MeOH/CH2Ch 
= 5%) to afford 94 (0.84 g) as a syrup. 
Yield: 84% 
Rf: 0.27 (Methanol : dichloromethane 5: 95) 
[afoD = +22.7 (c = 1, CHCI3) 
1H NMR (300 MHz, CDC!}): 86.90-6.87 (1 H, d, J = 7.97 Hz, NH), 5.30-5.28 (1 
H, dd, J = 3.30, 6.60 Hz) , 5.16-5 .10 (2 H, m), 4.78-4.72 (1 H, dt, J = 7.69, 4.95 
Hz,H-3'), 4.49-4.40 (2 H, m), 4.30-4.24 (1 H, dd, J = 4.81, 11.95 Hz), 4.07-4.04 
(1 H, dd, J = 5.08, 11.90 Hz), 3.79 (3 H, s, OCH 3), 2.80-2.78 (2 H, m, H-4'), 
2.69-2.61 (1 H, dd, J= 8.79,15.38 Hz, Ha-l '),2.60-2.54 (1 H, dd, J= 4.40,15.38 
Hz, Hb-l ') ,2.11-2.08 (12 H, m, OCOCH3), 2.07 (1 H, s, H-6 ') . 
13	 I:C NMR (75 MHz, CDClJ) : U 171.0, 170.2, 169.9, 169.9, 169.0 (O~OCH 3 . 
C-2', C-7'), 78.8 (C-5') , 72.5, 72.2, 69.5, 69.3, 68.1, 67.8, 61.8 (C-6'), 53.1 (C-3'), 
51.1 (C-8'), 37.4 (C-l ') ,22.6 (C-4'), 21.2, 21.1, 21.0 (OCO~H 3) . 
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IV Synthesis of a-D-mannopyranoside derivatives modified at 
position 1 - series 1 of C-mannosides 
General procedure of click chemistry 
To solution of alcyne derivative (1 eq) in toluene, azido derivative (1.2- 2 eq), 
and CuI (1% molar) were added, and under nitrogen, DIPEA (1.2-1.5 eq) was 
added, the mixture was stirred overnight at room temperature. The mixture was 
then evaporated under reduced pressure. The residue was purified by flash 
chromatography on silica gel (MeOHlCH2Ch = 5%) to afford products as oil. 
Standard Zernplen deacetylation procedure 
The sugars were dissolved in methanol followed by the addition of a I M 
solution of sodium methoxide in methanol (0.5 - 1.0 eq). The reaction mixtures 
were stirred overnight at room temperature and neutralized with Amberlite resin 
IR-120 (H+), filtered, and evaporated under reduced pressure. The residue was 
purified by flash chromatography on silica gel (MeOH/CH2Ch = 15%) or 
lyophilized to afford sugars as a solid. 
Standard saponification procedure with LiOH solution (1M, THF: MeOH: 
HzO=3:2:1) 
The sugars were dissolved in LiOI-l solution, the mixture was stirred at room 
temperature until the reaction was finished as checked by TLC. Amberlite resin 
IR-120 (H+) was then added to adjust the pH to 7, filtered with filter paper, and 
washed with MeOH. The filtrate was evaporated under reduced pressure and the 
residues were lyophilized to afford sugars as solids. 
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IV.1 Synthesis of compound 100 
IV.1.0 Synthesis of compound 98 
11' 12' 2' HN0C0 2Me 
o 4'~N 
5' I '~N 
6' N 
D8' 8' 9' 9' 
10' 
Synthesis of compound 98 was accomplished by following the 'General 
procedure of click chemistry' described above using cyclohexyl azide and 
compound 94. 
Yield: 94% 
Rf: 0.24 (Methanol: dichloromethane 5: 95) 
[ex] 20 0 +21.2 (c = 1, CHCb)
 
IH NMR (300 MHz, CDCh): 8 7.38 (1 H, s, H-6'), 7.14-7.12 (1 H, d, J = 7.69
 
Hz, NH), 5.28-5 .24 (1 H, dd, J = 3.30, 7.14 Hz), 5.17-5.13 (2 H, m), 4.92-4 .86 (1
 
H, dd, J= 5.22,12 .91 Hz, H-3 '), 4.45-4.35 (2 H, m), 4.20-4.16 (1 H, dd, J= 4.40,
 
11.82 Hz), 4.05-4.00 (1 H, dd,J= 5.91,10.58 Hz), 3.72 (3 H, S, H-12'), 3.27-3.24 
(2 H, t, J = 5.22 Hz, H-4 ') , 2.68-2 .60 (1 H, dd, J = 8.79,15.11 Hz, Ha-l'), 
2.58-2 .51 (1 H, dd, J = 4.67, 15.11 Hz, Hb-l ' ), 2.19-2.16 (2 H, m), 2.09-2.05 (12 
H, m, OCOCH3), 1.97-1.90 (2 H, m), 1.78-1.66 (3 H, m), 1.54-1.43 (2 H, m), 
1.33-1 .25 (1 H, m). 
l3C NMR (75 MHz, CDCl 3) : 8 171.6, 170.9, 170.1, 170.0, 169.8, 169.0 
(O~OCH 3 , C-2 ' , C-ll '), 142.5 (C-5'), 120.1 (C-6'), 71.9 (C-l), 70.6 (C-5), 69.6 
89 
(C-2), 68.5 (C-3), 67.4 (C-4), 62.0 (C-6) , 60.3 (C-T) , 52.7 (C-3 ') , 52.2 (C-12 '), 
37.0 (C-l '), 33.6 (C-8 ') , 27.9 (C-I0'), 25.3 (C-9 ') , 21.0 , 21.0, 20.9 (4 x 
OCOGH3) .
 
MS (ESI): 625.5 [M+Ht, calcd. 625.27 for C28H4oN40 12 + l·t
 
IV.I.t Synthesis of compound 99 
11' 12' 
2' H 3'l' N",,-/C0 2Me 
° 4'?1cN 5' I ':N 
6' N 
b 8' 8' g' g' 
10' 
Deprotection of acetylated 98 was accomplished following the 'Standard 
Zernplen deacetylation proc edure' described above . 
Yield: 81% 
Rf: 0.53 (Methanol: dichloromethane 2: 8) 
[CXfOD +20 (c = 1, CH30H) 
IH NMR (300 MHz, CD30D): 8 7.80 (1 H, s, H-6'), 4.69-4.65 (1 H, dd, J = 
5.36,7.83 Hz, H-3'), 4.44-4.36 (1 H, m), 4.23-4.17 (1 H, m, H-l), 3.85-3.79 (1 H, 
dd,J= 6.59 , 11.81 Hz),3 .67-3 .63 (6H,H-12 'and3Hofsugar),3 .57-3.53(1 H, 
m), 3.24-3 .17 (1 H, dd, J= 5.22,14.83 Hz, Ha-4'), 3.13-3 .05 (1 H, dd, J= 8.10, 
14.83 Hz, Hb-4 ') , 2.64-2.56 (1 H,dd,J= 9.20,15.11 Hz, Ha-l ') , 2.50-2.44 (1 H, 
dd,J= 4.94,15.11 Hz, Hb-l '),2.11-2.06 (2 H, m), 1.88-1.83 (2 H, m), 1.79-1.68 
(3 H, m), 1.53-1.43 (2 H, m), 1.39-1.24 (2 H, m). 
l3 C NMR (75 MHz, CD30D): 8 174.0 (C-2'), 173.7 (C-l1 '), 144.2 (C-5'), 123.4 
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(C-6'), 78.3 (C-5), 74 .7 (C-1 ), 73.2 (C-3), 72.4 (C-2), 70.4 (C-4), 63.1 (C-6), 62 .3
 
(C-T), 54.6 (C-3 '), 53.8 (C- 12 ') , 38 .1 (C-1'), 35.2 C-8'), 29.3 (C-4 ') , 27 .0
 
(C-10 ') .
 
MS (ESI): 457.4 [M+Ht, calcd . 457. 23 for C2oH32N40 g + H+
 
IV.1.2. Synthesis of compound 100 
11' 
2' H 3' l' N"-.,/C02H 
o 4'?[N
5' I ':N 
D
6' N 
8' 
8' 9' 
9' 
10' 
Hydrolysi s of the methyl ester function of 99 was acc ompl ished foll owing 
the ' Standa rd sapo nifica tion procedure wi th a so lution of LiOH described above. 
Yield : 94% 
[exfoo +38 .5 (c = 1, CHJOH) 
'n NMR (300 MHz, CD30D): 8 7.80 (1 H, s, H-6'), 7.72 (1 H, s, NH), 4 .65 (1H, 
m, H-3'), 4.4 8 (1 H, b), 4 ,38 (1 H, m), 4.20 (1 H, m), 3.80 (1 H, m), 3.6 0 (3 H, m), 
3.20 (1 H, m, Ha-4 ' ), 3. 10 (1 H, m, Hb-4'), 2 .60 (1 H, m, Ha-1'), 2.45 (1 H, m,
 
Hb-1 '),2.10 (2 H, m), 1.78 (5 H, m), 1.42 (2 H, m), 1.25 (1 H, m).
 
13C NMR (75 MHz, CD30D): p 174.1 , 173 .7, 173.3 (C=O), 142.8 (C-5' ), 123.5
 
(C-6'), 78 .4 (C-5 ), 74 .9 (C-1), 73.2 (C-3), 72.6 (C-2), 70.3 (C-4), 63.1 (C-6), 62. 3
 
(C-T), 54 .6 (C-3'), 53 .8, 38 .0 (C -1'),35.3 (C-8'), 30.5 (C-4'), 29 .3 (C-10') , 27 .0
 
(C-9 ') .
 
MS (ESI): 443.4 [M+Ht, ca lcd . 443 .22 for Cl9HJoN40g + H+
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IV.2 Synthesis of compound 103 
IV.2.0 Synthesis of compound 101 
12' 13' 2' HN0C0 2Me 
o 4'?(N
5' I ':N 
6' N 
7~10' 
9,V11' 
10' 
Synthesis of compound 101 was accomplished by following the 'General 
procedure of click chemistry' described above using benzyl azide and compound 
94.
 
Yield : 95%
 
Rf: 0.18 (Methanol: dichloromethane 2: 8)
 
[afoD +22.9 (c = 1, CHCl ))
 
IH NMR (300 MHz, CDC!)): 8 7.32 (1 H, s, H-6'), 7.31-7.28 (2 H, m, H-I0'),
 
7.21-7.28 (3 H, m, H-9', H-ll'), 5.45 (2 H, s, H-T), 5.23-5.20 (1 H, dd,J=3.16,
 
7.56 Hz, H-3'), 5.13-5.09 (2 H, m), 4.83-4.81 (1 H, m), 4.38 (1 H, m), 4.28 (1 H,
 
m), 4.18-4.13 (1 H, m), 3.97-3 .95 (1 H, m), 3.62 (3 H, s, H-13'), 3.19-3.18 (2 H, d,
 
J = 4.67 Hz, H-4'), 2.64-2.56 (1 H, dd, J =8.65, 15.25 Hz, Ha-l '), 2.54-2.47 (1 H,
 
dd,J=4.94, 15.11 Hz, Hb-l') , 2.04-1.99 (12 H, m, OCOCH)).
 
I3 C NMR (75 MHz, CDC!)).: 8 171.6 (C-2'), 170.9 (C-12'), 170.2, 170.0, 169.8, 
168.9 (O.GOCH)), 143.4 (C-5'), 135.1 (C-8'), 129.3 (C-9'), 129.0 (C-I0') , 128.2 
(C-ll'), 123.0 (C-6 '), 72.0 (C-l), 70.5 (C-5), 69.5 (C-2), 68.5 (C-3), 67.4 (C-4), 
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62.0 (C-6), 54.2 (C-T), 52.7 (C-3'), 52.1 (C-13'), 36.9 (C-l'), 28.0 (C-4'), 21.1,
 
21.0, 20.9 (OCO.GH3) .
 
MS (ESI): 633.4 [M+Hr, calcd. 633 .24 for C29H36N4012+ H+
 
IV.2.1 Synthesis of compound 102 
12' 13' 
2' H 3'l' N"'-./COzMe 
° 4'?1[N5' I ':N 
6' N 
n, g, 7' I ~ 10' g' .--:::- 11' 
10' 
Deprotection of acetylated 101 was accomplished following the ' Standard 
Zemplen deacetylation procedure' described above. 
Yield: 73% 
Rf: 0.40 (Methanol : dichloromethane 2: 8) 
[ex] 20 D +22 .2 (c = 1, CH30H)
 
'n NMR (300 MHz, CD30D): 8 7.75 (1 H, s, H-6'), 7.35-7.23 (5 H, m, H-9',
 
H-I0', H-ll '), 5.51 (2 H, s, H-7'), 4.69-4.65 (1 H, dd, j = 5.49, 8.24 Hz, H-3'),
 
4.19 (1 H, m, H-l), 3.84-3.77 (1 H, dd, j = 6.87,11.81 Hz), 3.68-3.63 (4 H, m), 
3.61 (3 H, s, H-13') , 3.54-3.49 (I H, m), 3.23-3.17 (I H, dd, j = 5.22,14.83 Hz, 
Ha-4 ') , 3.11-3 .03 (1 H, dd, j = 8.24, 14.83 Hz, Hb-4 ') , 2.59-2 .51 (1 H, dd, j = 
9.34,14.83 Hz, Ha-l '),2.44-2.37 (1 H, dd, J> 4.95,14.83 Hz, Hb-l '). 
13C NMR (75 MHz, CD30D1: 8 174.0 (C-2') , 173.7 (C-12'), 145.5 (C-5 ') , 137.7 
(C-8'),130.9 (C-9'), 130.4 (C-I0'), 129.9 (C-ll ') , 125.5 (C-6'), 78.3 (C-5), 74.9 
(C-l), 73.2 (C-3), 72.5 (C-2) , 70.3 (C-4) , 63.1 (C-6) , 55.7 (C-7'), 54.5 (C-3') , 
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53 .8 (C-13 '),38.0 (C-l ' ) , 29.3 (C-4') .
 
MS (ESI): 465.4 [M+Ht, calcd. 465.20 for C2IH28N40g + H+
 
IV.2.2. Synthesis of compound 103 
2' H
12' 
N 3' CO H<:> 2 
o 4'-~N 
5' I ':N 
6' N
::o, g, 7' 1 "'-'::: 10' g' ..-::- 11' 
10' 
Hydrolysis of the methyl ester function of 102 was accomplished following 
the 'Standard saponification procedure with a solution of LiOH as described 
above. 
Yield: 95% 
Rf 0.2 (Methanol: dichloromethane 1: 1) 
[afoD +51.3 (c = 1, CH30B) 
'H NMR (300 MHz, CD30D + D20): 87.66 (1 H, s, H-6'), 7.24-7.19 (3 H, m, 
H-9', B-11 '),7.14-7.11 (2 H, m, H-10'), 5.39 (2 H, s, H-T), 4 .52 (1 H, 1, H-3'), 
4.09-4.08 (1 H, m), 3.63-3.49 (5 H, m), 3.36 (1 H, s), 3 .13-3 .10 (1 H, m, Ha-4'), 
2.99-2.92 (1 H, Hb-4 '),2.55-2.47 (1 H, m, Ha-l '),2.25-2.17 (1 H, m, Hb-l '). 
l3 C NMR (75 MHz, CD30D + D20): 8174.5 (C-12'), 173 .8 (C-l '),145.5 (C-5'), 
137.1 (C-8'), 130.9 (C-9') , 130.4 (C-10'), 129.8 (C-ll '),125 .7 (C-6'), 77.0 (C-5), 
76.1 (C-l), 72.8 (C-3), 72.7 (C-2), 69.4 (C-4), 62.8 (C-6), 55 .7 (C-T), 49.8 (C-3'), 
37.3 (C-1 '),29.1 (C-4') .
 
MS (ESI): 451.4 [M+Ht, calcd . 451.19 for C20H26N40g + l·t
 
94 
IV.3. Synthesis of compound 106 
IV.3.0 Synthesis of compound 104 
13' 14' 
2' HN~C02Me 
o 4'?[N
5' I ':N 
6' N 
7' 
110 
Synthesis of compound 104 was accomplished by following the 'General 
procedure of click chemistry' described above using azido tyramine acetate and 
compound 94. 
Yield: 59% 
Rf: 0.28 (Methanol: dichloromethane 5: 95) 
[afoD +6.8 (c = 1, CHCI)) 
'n NMR (300 MHz, CDC!)): 8 7.07 (I H, s, H-6'), 6.87-6.74 (4 H, m, H-I0', 
H-ll '), 5.24-5 .07 (2 H, m), 4.81-4.75 (I H, dd, J = 5.22 Hz, 7.42 Hz, H-3 '), 
4,62-4 .51 (1 H, m), 4.48-4.30 (3 H, m), 4.20-4.15 (I H, dd, J = 3.85, 12.36 Hz), 
4.02-3 ,97 (1 H, dd, J = 5,91 , 9.75 Hz), 3.47 (1 H, s), 3.71 (3 H, s, H-14'), 3.46 
(lH, s), 3.20-3.18 (2 H, d, J = 5,22 Hz, H-4'), 3,09-3 .05 (2 H, t, J = 6.46 Hz, 
H-8'), 2.66-2.61 (I H, dd, J = 8.79, 15.11 Hz, Ha-l '), 2.46-2.40 (I H, dd, J = 5.08, 
15.25 Hz, Hb-I '), 2.09-2 .03 (12 H, m , OCOCH)). 
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I3 C NMR (75 MHz, CDCh): 8 171.5, 171.3, 170.5, 170.4, 170.0, 169.0 
(O.GOCHJ.C-2', C-13'), 155.9 (C-I2 '), 142.2 (C-5'), 130.3 (C-9 ') , 128.6 (C-IO'), 
123.5 (C-6'), 116.0 (C-II'), 71.9 (C-I), 71.0 (C-5), 69.7 (C-2), 68.8 (C-3), 67.3
 
(C-4) , 62.3 (C-6), 53.0 (C-3') , 52.3 (C-I4'), 36.6 (C-8'), 36.1 (C-I '),27.9 (C-4'),
 
21.2,21.1 ,21.0 (OCO.GHJ) .
 
MS (ESI): 663.4 [M+Ht, calcd.663 .25 for CJoHJsN401J + H+
 
IV.3.1 Synthesis of compound 105 
OH 
Deprotection of acetylated 104 was accomplished following the ' Standard 
Zernplen deacetylation procedure ' described above. 
Yield: 43% 
Rf: 0.2 8 (Methanol: dichloromethane2: 8) 
[a]20D +15.2 (c = 1, CHJOH) 
'n NMR (300 MHz, CD30D): 8 7.55 (1 H, S, H-6'), 6.89-6.87 (2 H, d, J = 8.52 
Hz, H-IO '), 6.66-6.63 (2 H, d, J= 8.52 Hz, H-II ') , 4.66-4 .62 (1 H, m, H-3'), 
4.51-4.48 (2 H, t, J = 7.01 Hz, H-T), 4.21-4 .18 (1 H, m, H-I), 3.85-3 .79 (1 H, dd, 
J= 6.87,11.81 Hz), 3.69-3 .61 (8 H, m, H-I4', H-4', 3xHsucre) , 3.56-3.52 (1 H, 
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m), 3.21-3.14 (1H, dd, J = 5.49 , 15.11 Hz ), 3.01-3.06 (2 H, t, J = 7.28 Hz, H-8'),
 
2.62-2.54 (1 H, dd, J = 9.34 , 14.83 Hz, Ha-1 '),2.49-2.43 (1 H, dd, J = 4.94, 14.83
 
Hz, Hb-1 ').
 
13C NMR (75 MHz, CD30D): 8 174.0, 176.6 (C=O), 158.1 (C-12'), 144.6 (C-5') ,
 
131.6 (C-9'), 130.2 (C-10') , 125.6 (C-6'), 117.2 (C-ll'), 78.3 (C-5), 74.8 (C-1), 
73.2 (C-3), 72.4 (C-2), 70.4 (C-4) , 63.1 (C-6), 54.5 (C-3'), 53.8 (C-14'), 38.1
 
(C-1 '),37 .5 (C-8'), 29.2 (C-4 ') .
 
MS (ESI): 495.4 [M+Ht, calcd.495.21 for C22H30N409 + H+
 
IV.3.2 Synthesis of compound 106 
Hydrolysis of the methyl ester function of 105 was accomplished following 
the 'Standard saponification procedure with a solution of LiOH as described 
above. 
Yield: quantitative 
Rf: 0.08 (Methanol: dichloromethane2: 8) 
[afoD +23.5 (c = 1, H20) 
I H NMR (300 MHz, CD30D + D20): 87.59 (1 H, s, H-6'), 6.81-6.78 (2 H, d, J 
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= 8.21 Hz, H-10'), 6.53-6.51 (2 H, d, J> 8.21 Hz, H-11 '),4.50-4.46 (3 H, m, H-7' ,
 
H-3'), 4.21 (1 H, 1, H-l), 3.81-3.68 (4 H, m, H-7', 2 x Hsucre), 3.66-3.61 (1 H, m),
 
3.55-3.50 (1 H, m), 3.27-3.20 (1 H, dd, j = 4.12 , 14.83 Hz ),3 .08-3.03 (1 H, rn),
 
3.00-2.95 (2 H, t, j = 9.34 Hz, H-8') , 2.69-2.62 ( 1H, dd, j = 9.34, 14.83 Hz,
 
Ha-1 '),2.46-2.39 (1 H, dd, j= 4.94,14.83 Hz, Hb-1 ').
 
l3C NMR (75 MHz, CD30D + DzO): 8 178.3 (C-13 ' ), 173.4 (C-2'), 166.9
 
(C-12'), 145.7 (C-5'), 131.3 (C-6'), 125.5 (C-9'), 124.5 (C-10'), 120.6 (C-ll '),
 
77.5 (C-5), 75.7 (C-l), 72.9 (C-3) , 72.1 (C-2) , 69.9 (C-4), 63.0 (C-6) , 56.6 (C-7'),
 
54.1 (C-3'), 37.8 (C-1') , 37.5 (C-8'), 30.2 (C-4').
 
MS (ESI): 481.4 [M+Ht, calcd.481.20 for C21H28N409 + H+
 
IVA Synthesis of compound 108 and compound 109 
IV.4.0 Synthesis of compound 107 
Synthesis of compound 107 was accomplished by following the 'General 
procedure of click chemistry' described above using tert-butyl 2-azido acetate and 
compound 94. 
Yield: 99% 
98 
Rf: 0.25 (Methanol: dichloromethane 5: 95)
 
[0.]2°0 +26.9 (c = I , CHCI3)
 
I H NMR (300 MHz, CDCl3): 0 7.5 1 (I H, s, H-6' ), 7. 14-7 .11 ( I H, d, J = 7.69
 
Hz, NH), 5.22- 5.19 (1 H, dd, J = 3.16, 7.55 Hz), 5.13-5.09 (2 H, m), 5.0 I (2 H, s,
 
H-T ), 4.90-4.86 (1 H, dd , J = 5.22, 12.91 Hz, H-3' ), 4.39-4.30 (2 H, m),
 
4.29-4 .11 (1 H, dd, J = 3.98,1 1.95 Hz), 3.98-3.93 (1 H, dd, J = 6.04, 10.16 Hz),
 
3.70 (3 H, s, H-1 2 ' ), 3.27-3.25 (2 H, d, , J = 5.22 Hz, H-4 ' ), 2.65-2.51 (2 H, m,
 
H-I '),2.05-2.01 (12 H, m, OCOCH3), 1.44 (9 H, s, H-I O' ).
 
13C NMR (75 MHz, CDC}3l: 2) 171.6 (C-2'), 170.9 (C- I I ' ), 170.1, 170.0, 169.8,
 
168.9 (O.GOCH3), 169.7 (C-8'), 143.2 (C-5'), 124 .0 (C-6 '), 83.9 (C-9'), 72.1
 
(C- I), 70.4 (C-5), 69.4 (C-2), 68 .4 (C-3), 67.3 (C-4), 6 1.9 (C-6), 52.9 (C-7' ), 52.0
 
(C-3'), 51.7 (C- 12'), 36.9 (C- I '), 28.2 (C-4'), 28 .0 (C- IO ') , 21. 1, 2 1.0, 20 .9
 
(OCO.GH3).
 
MS (ESI): 657.4 [M+Hr , calc d. 657.26 for C28H40N4014 + H+
 
IV.4.1a Synthesis of compound 108 
Deprotection of acetyla ted 107 was accomplished following the 'Standard 
Zernplen deacetylation proce dure' described above. 
99 
Yield: 3 1%
 
Rf: 0.30 (Methanol: dichloromethane 2:8)
 
[CX] 20D +13.1 (c = 1, CH30 H)
 
I H NMR (300 MHz, CD30D): 8 7.87 (1 H, s, H-6' ), 5.3 1 (2 H, s, H-T), 4.75 (1
 
H, b, H-3'), 4 .24 (1 H, m, H-1), 3.78 (3 H, s, H-12' ), 3.72 (3 H, m), 3.68 (2 H, m),
 
3.56 (1 H, b), 3.25 (1 H, m, Ha -4 '), 3.18 (1 H, m, Hb-4 '), 2.64 (1 H, dd,J= 9.34, 
14.83 Hz, Ha- 1'),2.51 (1 H, dd, J = 4.95,14.83 Hz, Hb-1 ') , 1.28 (9 H, s, H-10').
 
I3C NMR (75 MHz, CD30D).: 8 173.4 (C-2'), 173.4 (C- 11'), 169.6 (C-8'), 77.9
 
(C-5), 74.8 (C- 1), 73.0 (C-3), 72 .3 (C-2), 70.0 (C-4), 62.8 (C -6), 54.1 (C-3' ) , 53.9
 
(C- 12'), 53.5 (C-T), 37.7 (C- 1'),3 1.3 (C-4'), 29.0 (C- 10') .
 
MS (ESI): 489.5 [M+Ht, calc d.489.22 for C20H32N40 IO + H+
 
IVA.1b Synthesis of compound 109 
9' 10' 
2' H 3'l' N,,-/COzMe 
o 4'?[N
5' I '~N 
6' N 
7~O 
8'OH 
Deprotection of ace tylated 107 was accomplished. followi ng the 'S tandard 
Zemplen deacetylation procedure ' desc ribed above. 
Yield: 4 1% 
Rf: 0.19 (Methanol: dichlorometh ane 1:1) 
[CX] 20D +30 .5 (c = 1, CH30H)
 
IH NMR (300 MHz, D20): 8 7.69 (1 H, s, H-6'), 4.89 (2 H, s, H-T ), 4.21-4.16 (1
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H, m, H-l), 3.74-3.69 (2 H, m), 3.64-3.53 (6 H, m, OMe), 3.45-3.41 (1 H, m),
 
3.22-3.12 (2 H, m, H-4'), 2.70-2.62 (1 H, dd, j = 9.75, 14.97 Hz, Ha-l '),
 
2.45-2.39 (1 H, dd, j= 5.08,14.97 Hz, Hb-l ').
 
l3 C NMR (75 MHz, 020):.0 173.4 (C-8'), 172 .9 (C-2'), 172.6 (C-9'), 125.5
 
(C-6') , 80 .1 (C-5), 75 .0 (C-1), 70 .8 (C-3), 70 .6 (C-2), 67 .1 (C-4), 61.0 (C-6), 53.2
 
(C-T), 52 .7 (C-3 '), 52.6 (C-IO'), 35.1 (C-l ' ), 26.9 (C-4') .
 
MS (ESI): 433 .5 [M+Ht, calcd.433.16 for C16H24N40,O + H+
 
IV.5 Synthesis of compound 112 
IV.5.0 Synthesis of compound 110 
11' 12' 2' HN~C02Me 
o 4'-?[N
5' I ':N 
6' N 
7\ ...0
"80' 
o
"I 9' 
110' 
Synthesis of compound 110 was accomplished by following the 'General 
procedure of click chemistry' described above using ethyl 2-a zido acetate and 
compound 94. 
Yield: 77% 
Rf: 0.19 (Methanol : dichloromethane 5:95) 
[afoo +31.3 (c=1,CHC1 J ) 
I H NMR (300 MHz, CDC!]): 0 7.54 (1 H, s, H-6'), 7.20-7 .15 (1 H, t, j = 6.87 Hz, 
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NH) , 5.21-5.18 (1 H, dd, J = 3.17, 7.56 Hz), 5.13-5.09 (4 H, m, H-T), 4. 87-4. 85 
(1 H, d, J = 6.87 Hz, H-3'), 4 .37-4 .27 (2 H, m, H-I), 4.23-4.16 (2 H, q, J = 7.14 
Hz H-9 ' ), 4 .14-4.09 (1 H, dd, J = 2.89, 11.95 Hz), 3.97-3.94 (1 H, dd, J = 6.04, 
9.89 Hz), 3.69 (3 H, S, H-12 '), 3.26 (2 H, s, H-4'), 2.62-2.57 (2 H, m, H-I '), 
2.04-1.99 (12 H, m, OCOCH3), 1.27-1.22 (3 H, t, J= 7.14 Hz, H-I O'). 
DC NMR (75 MHz, CDCh).: 8 171.6 (C-2 ' ), 170.9 (C- I I '), 170.2, 170.1, 169.8, 
169.0 (O~OCH 3), 166.7 (C-8'), 143.2 (C-5'), 124.2 (C-6 ') , 71.9 (C- I), 70.7 (C-5), 
69.4 (C-2), 68.5 (C-3), 67.2 (C-4) , 62.5 (C-6), 62.0 (C-9 ') , 52.9 (3'), 52.0 (12'), 
51.0 (C-T), 36.7 (C-I '),27.9 (C-4'), 21.1, 21.0, 20.9 (OCO~H3), 14.3 (C-IO') . 
MS (ESI): 629.4 [M+Ht, calcd.629.23 for C26H36N40 14 + H+ 
IV.5.1 Synthesise of compound 111 
Deprotection of acetylated 110 was accomplished following the 'Standard 
Zernplen deacetylation procedu re ' described above. 
Yield: 88% 
Rf: 0.28 (Methanol: dichloromethane 20:80) 
[a f oD +23.4 (c = I , CH30 H) 
I H NMR (300 MHz, CD30 D): 8 7.87 (1 H, s, H-6 ' ), 5.32 (2 H, s, H-T ), 
4.78-4.73 (1 H, dd, J= 5.22, 7.97 Hz, H-3' ), 4.27-4 .2 1 (1 H, m, H-I ), 3.86-3 .80 
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(1 H, m), 3.78 (3 H, s, CH3), 3.72 (3 H, s, CH 3), 3.68-3.64 (4 H, m) , 3.58-3 .54 (1
 
H, m), 3.31-3.25 (1 H, dd ,
 
J=5.22, 15.11 Hz, Ha-4') , 3.20-3.13 (1 H,dd,J= 8.24, 15.11 Hz, Hb-4') ,
 
2 .70-2.61 (1 H,.dd,J=9.20, 14.97 Hz, Ha-l'), 2.55-2.48 (1 H,dd,J =5 .08, 14.97
 
Hz, Hb-l ' ).
 
13C NMR (75 MHz, CD30D): 8173.9 (C-2 '), 173 .7 (C-I0 '), 169.9 (C-8 ') , 145.3
 
(C-5'), 127.0 (C-6') , 78 .1 (C-5), 75.1 (C-l), 73 .2 (C-3), 72.5 (C-2), 70 .2 (C-4),
 
63.1 (C-6), 54.4 (C-3') , 54 .2 (C-ll '), 53.8 (C-9'), 52.4 (C-T), 38.0 (C-l ' ), 29.2
 
(C-4 ') .
 
MS (ESI): 447.4 [M+Ht, calcd.447.18 for C17H26N40 10 + H+
 
IV.5.2 Synthesis of compound 112 
Hydrolysis of the methyl ester function of 111 was accomplished foJJowing 
the 'Standard saponification procedure with a solution of LiOH as described 
above. 
Yield : 99% 
Rf: 0.18 (Methanol: dichloromethane 20:80) 
[0:]20D +33.5 (c = 1, CH 30H) 
I H NMR (300 MHz, CD30D): 87.77 (1 H, s, H-6'), 4.77 (1 H, s, H-3 ') , 4.25 (1 
103 
H, s, b, H-l), 3.84-3.79 (1 H, m), 3.74 (2 H, s, H-7'), 3.72-3 .60 (4 H, m),
 
3.57-3 .55 (1 H, m), 3.22 (2 H, bs, H-4'), 2.68-2.60 (1 H, dd, J = 8.65 , 14.70 Hz,
 
Ha-1 '),2.58-2.51 (1 H, dd, J = 5.63 , 14.70 Hz, Hb-1 ').
 
l3 C NMR (75 MHz, CD30D).: 8 174.0 (C-9'), 173.8 (C-8'), 173 .5 (C-2'), 127.0
 
(C-6'), 78.0 (C-5), 75.4 (C-1), 73.1 (C-3), 72.6 (C-2), 70.2 (C-4), 63.1 (C-6), 54.3
 
(C-3 '), 53.8 (C-7'), 37.9 (C-1 '),29.2 (C-4 ').
 
+ ~ +MS (ESI): 419.6 [M+H] , calcd.4 19.14 lor CIsH22N401O + H 
IV.6 Synthesis of compound 115 
IV.6.0 Synthesis of compound 113 
11' 12' 
2' H 3' l' N"-../"C02Me 
° 4'?(N5' I ~N 
6' N7'}8'
9'
° 0'...... 10' 
Synthesis of compound 113 was accomplished by following the 'General 
procedure of click chemistry' described above using methyl 3-azido propionate 
and compound 94. 
Yield: 92% 
Rf: 0.20 (Methanol: dichloromethane 5: 95) 
[a]20D+24.0 (c = I, CHC1J) 
I H NMR (300 MHz, CDCl3) : 8 7.46 (1 H, s, H-6 '), 7.16-7.13 (1 H, d, J = 7.69 
Hz , NH), 5.20-5 .16 (1 H, dd, J = 3.30, 7.69 Hz, Ha-6), 5.09-5 .07 (2 H, Hb-6, H-2) , 
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4.84-4.77 (1 H, dd, j = 5.22, 12.91 Hz, H-3'), 4.57-4.52 (2 H, t, j = 6.46 Hz,
 
H-8') , 4.38-4.32 (1 H, m, H-l), 4.29-4.23 (1 H, dd, j = 5.76, 12.09 Hz, H-4),
 
4.14-4.09 (1 H, dd, j= 3.98,12.45 Hz,"H-5), 3.97-3 .92 (1 H, dd, j= 5.91,10.30
 
Hz, H-3) , 3.65 (3 H, s, CH3), 3.62 (3 H, s, CH3), 3.19-3.17 (2 H, d, j = 5.22 Hz,
 
H-4 '), 2.90-2.86 (2 H, t, j = 6.46 Hz, H-8 ' ), 2.65-2 .57 (1 H, dd, j = 8.52, 15.11 Hz,
 
Ha-l '), 2.55-2.48 (I H, dd, j = 5.22, 15.11 Hz, Hb-l '), 2.02-1.97 (12 H, m,
 
OCOCH3).
 
13C NMR (75 MHz, CDCh): 8 171.5, 171.1, 170.9, 170.1, 170.0, 169.8, 168.9
 
(O~OCH3, C-2', C-9', C-ll ' ), 142.8 (C-5'), 123.4 (C-6'), 71.9 (C-l), 70.7 (C-5),
 
69.5 (C-2), 68.5 (C-4), 67.3 (C-3) , 62.0 (C-6), 52.7 (C-3'), 52.3 (C-12'), 52.0 
(C-IO'), 45.7 (C-7'), 36.8 (C-l ' ), 34.5 (C-4'), 27.8 (C-8'), 21.0, 21.0, 20.9, 20.9 
(OCO~H3) . 
MS (ESI): 629.4 [M+Ht, calcd.629.23 for C26H36N40 14 + H+ 
IV.6.1 Synthesis of compound 114 
Deprotection of acetylated 113 was accomplished following the 'Standard 
Zemplen deacetylation procedure' described above. 
Yield: 74% 
Rf: 0.25 (Methanol: dichloromethane 20: 80) 
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[a]20o +20 .8 (c = 1, CH30H) 
'n NMR (300 MHz, CD30D): 8 7,83 (l H, s, H-6'), 4,75-4 ,70 (l H, dd, J= 5.22, 
7,97 Hz, H-3'), 4,66-4,62 (2 H, t, J = 6,59 Hz, H-T), 4,25-4,21 (l H, m, H-l), 
3,87-3,81 (l H, dd, J = 6,59, 11.81 Hz), 3,71 (3 H, s, CH 3) , 3,67 (3 H, s, CH3) , 
3,71-3 ,67 (4 H, m), 3,60-3 ,55 (I H, m), 3,21-3 ,28 (1 H, dd,J= 5,22,15 ,11 Hz, 
Ha-4'), 3.16-3 .08 (1 H, dd, J = 8,24, 14.83 Hz, Hb-4 '), 2,00-1.96 (2 H, t, J = 6.59 
Hz, H-8'), 2,69-2,61 (l H, dd, J = 9,07, 14,83 Hz, Ha-l '),2,55-2.49 (1 H, dd, J = 
5,08,14.83 Hz, Hb-I '), 
13C NMR (75 MHz, CD30D): 8 173.1, 172,8, 172,6 (C=O), 144,0 (C-5'), 125,1 
(C-6'), 77.4 (C-5), 74,1 (C-l), 72.4 (C-3), 71.7 (C-2), 69.5 (C-4), 62.2 (C-6) , 53,6 
(C-3'), 53.0 (C-12'), 52,5 (C-I0'), 46,9 (C-T), 37 ,2 (C-l '), 35.1 (C-4') , 28.4 
(C-8') , 
MS (ESI): 461.4 [M+Ht, calcd.461.19 for C1 sH2SN4010 + H+ 
IV.6.2 Synthesis of compound 115 
2' H
10' 
N 3' CO H ~ 2 
o 4'?1[N
5' I ':N 
6' N 
7'~ 8' 
,~9' 
o OH 
Hydrolysis of the methyl ester function of 114 was accomplished following 
the 'Standard saponification procedure with a solution of LiOH as described 
above, 
Yield : quantitative 
106 
[cx.foo + 41.1 (c = 1, CH30H) 
I H NMR (300 MHz, CD)OD): 8 7.83 (1 H, 1, H-6 ') , 4.64-4.60 (2 H, t, J =6.40 
Hz, H-T), 4.24 (l H, b, H-3'), 3.81 (1 H, b), 3.72-3.49 (6 H, m), 3.57 (1 H, m), 
3.13 (1 H, b, Ha-4'), 3.00-2.95 (2 H, r, J= 7.09 Hz, H-8 '), 2 .82 (1 H, b, Hb-4'),
 
2.69-2.61 (1 H, m, Ha-l '),2.55-2.48 (1 H, m, Hb-l ').
 
DC NMR (75 MHz, CD)OD): 8 172.5, 172.0,171.5 (C=O), 123.8 (C-6'), 76.3
 
(C-5), 73 .0 (C-l), 71.1 (C-3) , 70 .6 (C-2) , 68.4 (C-4) , 61.1 (C-6 ), 51.3 (C-3 '), 45 .7
 
(C-T ), 36.1 (C-l '), 33.9 (C-8 '), 28.2 (C-4').
 
MS (ESI): 433.5 [M+Hf, calcd.433.16 for CIGH24N4010 + H+ 
IV.7 Synthesis of compound 118 
IV.7.0 Synthesis of compound 116 
10' 11' 
2' HN0C0 2Me 
o 4'~N 
5' I '~N 
6' N 
7'~ 8' 
9' 
Synthesis of compound 116 was accomplished by following the ' General 
procedure of click chemistry' described above using propyl azide and compound 
94. 
Yield : 80%
 
Rf: 0.30 (Methanol: dichloromethane 5: 95)
 
[cx.foo +27 .8 (c = 1, CHCh)
 
I H NMR (300 MHz, CDCh): 8 7.35 (1 H, s, H-6'), 7.22-7.20 (1 H, d, J = 6.32
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Hz, NH) , 5.20-5.1 7 (1 B , m, B-3), 5.11-5 .06 (2 B , m, H-2, H-4), 4 .83-4 .80 (1 H, 
m, H-3'), 4.36-4 .34 (1 H, m, B-1), 4.27-4.19 (3 H, m, Ha-6, H-T), 4.14-4 .10 (l H, 
m, Hb-6), 3.96-3.94 (1 H, m, H-5), 3.63 (3 H, s, H-ll ') , 3.18 (2 H, b, H-4 ') , 
2.65-2.57(1 H,dd,J= 8.71, 15.11 Hz, Ha-l ' ), 2.54-2.47 (1 H,dd,J =4.81, 15.11 
Hz, Hb-l '), 2.02-1. 96 ( 12 H, m,OCOCHJ), 1.88-1.80 (2 H, m, H-8'), 0.88-0.81 (3 
H, m, H-9'). 
l3 C NMR (75 M Hz, CDCb): 0 171.2, 170.4, 169.7, 169.5, 169.3 , 168.5 
(O~OC HJ ,C -2', C I0'), 142.4 (C-5' ), 121.9 (C-6') , 71.5 (C- l), 70.2 (C-5), 69.1 
(C-2), 68.0 (C-4), 66.9 (C-3), 61.5 (C-6), 52.3 (C-T), 51.6 (C-3' ), 5 1.6 (C- ll '), 
36.5 (C-l '), 27.5 (C-4') , 23.4 (C-8'), 20.6, 20.5, 20.5, 20.5 (OCO~HJ ) , 10.7 
(C-9'). 
MS (ESI ): 585.4 [M+r-rf, calcd.585.24 for C2S H36N40 12 + H+ 
IV.7.1 Synthesis of compound 117 
10' 11' 
2' H N ~C02Me 
o 4'?(N
5' I ~N 
6' N 
7' ~ 8' 
9' 
Deprotection of acety lated 116 was accomplished following the ' Standard 
Zempl en deacetylation procedure ' described above. 
Yield: 75% 
Rf: 0.30 (Methanol: dichloromethane 2: 8) 
[0.]2°0 +26.8 (c = 1, CH30H) 
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IH NMR (300 MHz, CD30D): 8 7.81 (1 H, s, H-6'), 4.87 (s, OH), 4.74-4.70 (l H,
 
dd,J= 5.36, 7.83 Hz, H-3') , 4.35-4 .31 (2 H, t,J= 6.87 Hz, H-T), 4.26-4.23 (1
 
H, m, H-l), 3.88-3.82 (1 H, dd, J = 6.59,11.8 1Hz), 3.71 (7 H, b, H-11', 4 x
 
Hsucre), 3.58 (1 H, I), 3.29-3.22 (1 H, dd, J= 5.22,14.56 Hz, HaA'), 3.18-3.10 (1
 
H, dd, J = 8.24, 15.11 Hz, Hb-4'), 2.69-2.61 (1 H, dd, J = 9.48, 14.70 Hz, Ha-l '),
 
2.54-2.48 (1 H, dd , J = 4.81, 14.97 Hz, Hb-l '), 1.93-1.86 (2 H, q, J = 7.14 Hz,
 
H-8 '), 0.92-0.87 (3 H, t, J= 7.42 Hz, H-9') .
 
13C NMR (75 MHz, CD30D): 8 173.2, 172.9 (C-2 ', C-I0'), 144.1 (C-5'), 124.6
 
(C-6'), 77.4 (C-5) , 74 .1 (C-l), 72.4 (C-3), 71.6 (C-2), 69.4 (C-4), 62 .2 (C-6), 53.7
 
(C-7'), 53.0 (C-3'), 52.9 (C-11 '), 37.2 (C-I '), 28.4 (C-4'), 24.6 (C-8'), 11.2
 
(C-9').
 
MS (ESI): 417.4 [M+I-It , calcd.417.20 for C17H28N40g+ H+
 
IV.7.2 Synthesis of compound 118 
10' 
2' H 3' l' N'-../C02H 
o 4'?(N
5' I ':N 
6' N 
7'~ 8' 
9' 
Hydrolysis of the methyl ester function of 117 was accomplished following 
the 'Standard saponification procedure with a solution of LiOH as described 
above. 
Yield: 91% 
Rf: 0.18 (Methanol: dichloromethane 2: 8) 
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[a]20D +53.6 (c = 1, CHCI3) 
I H NMR (300 MHz, CD30D) : 8 7.78 (1 H, bs, H-6 ' ), 4.56 (1H, bs), 4.33-4.28 (2
 
H, t, J = 7.01 Hz, H-T ), 4.24 (1 H, b), 3.91-3.80 (1 H, b), 3.71- 3.64 (5 H, b),
 
3.31-3.29 (1 H, b, Ha-4 ' ), 3.12 (1 H, b, Hb-4'), 2.65-2.60 (1 H, m, Ha-l '),
 
2.52-2.47 (1 H, m, Hb-l '),1. 89 (2 H, q, J = 6.93 Hz, H-8'), 0.91 (3 H, t, J = 6.93
 
Hz, H-9').
 
13C NMR (75 MHz, CD30D): 8 172.6 (C=O), 124.5 (C-6'), 77.6 (C-5), 74.0
 
(C- l), 72.3 (C-3), 71.7 (C-2), 69.6 (C-4), 62.3 (C-6), 52.9 (C-3'), 37.5 (C-I '),
 
29 .6 (C-4 ') , 24.6 (C-8 '), 11 .3 (C-9 ').
 
MS (ESI): 403.4 [M+Ht, calcd .403.19 for CI6H26N408+ H+
 
IV.8 Synthesis of compound 119 
AC~OAcO-0 
AcO 
AcO 11' 12' 
l ' (~ yC02Me 
o 4'-?(N
5' I ':N 
6' N 
~OHMe02C 
10' 9' 8' 
Synth esis of compound 119 was acco mplished by following the ' General 
procedure of click chemistry ' described above using azido-methyl L-serine and 
compound 94. 
Yield: 7% 
Rf: 0.19 (Methanol: dichloromethane 5: 95) 
[a]20D +23.6 (c = 1, CHCb) 
IH NMR (300 MHz, CDCh): 8 7.94 (1 H, s, H-6 '), 7.06-7 .03 (1 H, d, J = 7.69 
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Hz, NH), 6.52 (1 H, s), 6.47 (1 H, s), 5.29-5.29 (1 H, m, H-3), 5.16-5.11 (2 H, m), 
4.96-4.90 (1 H, m, H-3') , 4.45-4.39 (1 H, m, H-l), 4.40-4 .34 (1 H, dd, J = 6.32, 
12.09 Hz, Ha-6), 4.25-4 .19 (1 H, dd, J= 4.40,12.09 Hz, Hb-6), 4.05-3.99 (1 H, m,
 
H-5), 3.92 (3H, s, CH3), 3.76 (3 H, s, CH3), 3.34-3 .33 (2 H, d, J = 5.22 Hz, H-4'),
 
2.69-2.61 (1 H, dd, J = 8.79, 15.38 Hz, Ha-l), 2.60-2 .53 (1 H, dd, J = 4.95, 15.38
 
Hz, Hb-l), 2.09-2.07 (12 H, m, OCOCH3).
 
13C NMR (75 MHz, CDCl3): 8 171.6, 171.1, 170.3, 170.1, 170.0, 169.1
 
(OCOCH3,C-2', C-9', C-ll'), 142.9 (C-5'), 134.0 (C-6'), 72.4 (C-l), 70.1 (C-5),
 
69.5 (C-2), 68.4 (C-3), 67.7 (C-6), 62.0 (C-4), 53.6 (C-I0') , 53.1 (C-3'), 52.2
 
(C-8'), 52.2 (C-12'), 37.3 (C-I '), 30.1 (C-4'), 27.9, 21.2 (OCOCH3), 21.1
 
(OCOCH3), 21.1 (OCOCH3).
 
MS (ESI): 646.4 [M+Ht, calcd .645.23 for C26H36N4015 + H+
 
V. Synthesis of a-D-mannopyranosides derivatives modified at 
anomeric position - series 2 of C-mannosides 
V.O	 Synthesis of N-propargyl1'-(2, 3, 4, 6-tetra-O-acetyl-a-D-manno 
pyranosyl)ethanamide 120 
-0 
AcO 
2' H ~ 5' 
l' (N~/ 
AcOA~CCO
4' 
o	 3' 
To solution of 94 (0.314 g, 0.804 mmol) in DCM (7 ml), propargylamine 
(0.055 ml, 0.80 mmlo) and BOP( 0.437 g, 1.23 mmol) were added successively, 
then under nitrogen DIPEA (0.45 ml, 3.2 mmol) was added, the reaction was 
III 
stirred ove rnight at room temperature. The mixture was then evaporated under
 
reduced pressure, the residue was washed with 1 M KH S0 4 , 1 M NaOH, and
 
brine, dried over Na2S04, and purified by flash chromatography on silica gel
 
(MeOH/CH2Ch = 1.6%) to afford 120 (0.229 g) as a syrup.
 
Yield: 67 %
 
Rf: 0.15 (Methanol: dichlorome thane 1: 19)
 
[a f oD +1 3.1 (c = 1, CHCb)
 
'n NMR (300 MHz, CDCb): 0 6.70 (1 H, NH), 5.27-5. 21 (1 H, dd, J = 3.29,
 
6,59 Hz), 5.08-5.02 (2 H, m), 4.43-4. 34 (2 H, m), 4.20-4.15 (1 H, dd, J = 3.57,
 
12.09 Hz), 4.05-3.99 (3 H, m, 2 x H-3 '), 2.64-2.56 (1 H, dd, J = 9.61, 15.38 Hz,
 
Ha-l' ), 2.53-2.46 (1 H, dd, J = 4.12, 15.38 Hz, Hb-l ' ), 2.24-2 .22 (1 H, t, J = 2.47
 
Hz, H-5' ), 2.08-2.04 (12 H, m, 4 x OCOCH)).
 
I3 C NMR (75 MHz, CDC])): 0 170.5, 169.7, 169.5, 169.4, 168.6 (O.GOCH),
 
C=O), 79.4( C-4 '), 72.1 (C-l), 71.6 (C-5), 69.0 (C-2), 67.6 (C-3), 67.4 (C-4), 61.4
 
(C-6), 36.7 (C-l '), 29 .0 (C-3 ')
 
MS (ESI): 42 8.4 [M+Ht , calcd. 428.16 for C I9 H25N 10 10 + rr
 
V.1 Synthesis of compound 124 
V.l.1 Synthesis of compound 123 
OH 
,1/ '\( 11' 
9 10' 
AC~CO -9'8'-0 6' 
AcO 7' 
AcO 5' N 
2' H 4.~,rII 'N l' N~~~ 
( 3' N 
o 
Synthesis of comp ound 123 was acco mplished by following the 'G enera l 
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procedure of click chemistry' described above using azido tyramine and 120.
 
Yield: 90 %
 
Rf: 0.12 (Methanol : dichloromethane I : 19)
 
[a]20o +9 .78 (c = I, CHC!)
 
IH NMR (300 MHz, CDCh): 0 8.10 ( I H, bs, OH), 7.80 (I H, bs, NH), 7.38 (1
 
H, s, H-5'), 6.87-6.84 (2 H, d, J= 8.52 Hz, H-9'), 6.73-6.71 (2 H, d, J = 8.24 Hz,
 
H-IO'), 5.27-5 .23 (1 H, dd, J =3.30 Hz, 8.24 Hz), 5.16-5.11 (2 H, m), 4.53-4.34 (5
 
H, m, H-3', H-6') , 4.32-4.26 (1 H, m), 4.12-4 .07 (1 H, dd, J = 3.02 Hz, 12.09 Hz),
 
4.03-3.99 (I H, m), 3.05-3 .01 (2 H, t, J = 7.01 Hz, H-T), 2.76-2.68 (1 H, dd, J =
 
9.89 Hz, 14.83Hz, Ha-I '), 2.57-2.50 (1 H, dd, J = 4.54 Hz, 14.83 Hz, Hb-I '),
 
2.06-2.00 (12 H, m, OCOCH3).
 
I3 C NMR (75 MHz, CDCh): 0 170.7, 170.1, 169.8, 169.5, 169.3 (0~OCH3,
 
C=O), 155.6 (C-II '), 144.2 (C-4'), 129.6 (C-8'), 127.8 (C-5'), 123.1 (C-9'), 115.6
 
(C-IO'), 71.4 (C-I) , 70.8 (C-5), 69.5 (C-2), 68.3 (C-4), 67.0 (C-3), 61.8 (C-6),
 
51.8(C-6'), 36.3 (C-3') , 35.6 (C-7'), 34.6 (C-I '), 20 .7 (OCO~H 3), 20.6
 
(OCO~H 3). 
MS (ESI): 591.4 [M+Ht, calcd. 591.23 for C27H34N4011 + H+ 
V.1.2 Synthesis of compound 124 
6' 8' 
r5' N 
2' HJ{'I 'Nl' N ~ N 
3'o 
Deprotection of acetylated 123 was accomplished following the ' Standard 
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Zemplen deacetylation procedure' described above.
 
Yield : 70 %
 
Rf: 0.10 (Methanol: dichloromethane 20: 80)
 
[a]20D +17.9 (c = 1, CH30H) 
IH NMR (300 MHz, CD30D): 8 7.64 (I H, s, H-5'), 6.89-6.87 (2 H, d, j = 8.52
 
Hz, H-9'), 6.64-6.61 (2 H, d, J = 8.52 Hz, H-l 0') , 4.51-4.46 (2 H, t, j = 7.14 Hz,
 
H-6 '), 4.36-4 .35 (2 H, d, j = 7.02 Hz, H-3') , 4.27-4 .22 (1 H, m, H-l), 3.85-3 .78 (1
 
H, dd, j =7.14 Hz, 11.81Hz), 3.68-3.59 (4 H, m,), 3.56-3 .52 (1 H, m), 3.05-3 .00 (2
 
H, t, J = 7.14 Hz, H-T), 2.61-2 .53 (1 H, dd, j = 9.48 Hz, 14.83 Hz, Ha-I'),
 
2.50-2.44 (1 H, dd, J> 4.81 Hz, 14.83Hz, Hb-l ')
 
I3C NMR (75 MHz, CD30D): 08: 173.3 (C=O), 157.7 (C-ll'), 146.1 (C-4 '),
 
130.8 (C-8'), 129.1 (C-5'), 124.5 (C-9'), 116.6 (C-I0 '), 77.6 (C-5), 73.8 (C-I) ,
 
72.4 (C-3), 71.7 (C-2), 69.7 (C-4), 62.2 (C-6), 53.0 (C-6'), 37.5 (C-3 '), 36.7
 
(C-I '), 35.7 (C-T).
 
MS (ESI): 423.4 [M+Hr, calcd. 423.19 for CI9H26N407 + H+
 
V.2	 Synthesis of compound 126 
V.2.! Synthesis of compound 125 
~8' 
5' N 7' 
2' H 4~rr NN~N' 
3'o 
Synthesis of compound 125 was accomplished by following the 'General 
procedure of click chemistry' described above using allyl azide and compound 
120. 
Yield : 43% 
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Rf: 0.24 (Methanol: dichloromethane 5: 95)
 
[a]20o +12 .9 (c = 1, CHCIJ)
 
'n NMR (300 MHz, CDClJ): 87.59 (1 H, s, H-5'), 7.42 (1 H, s, NH), 6.04-5 .95
 
(1 H, m, H-T), 5.36-5.24 (3 H, m, H-8'), 5.13-5 .09 (2 H, m), 4.96-5.94 (2 H, d, J
 
= 6.32 Hz, H-6'), 4.50-4.32 (4 H, m, H-3'), 4.17-4 .11 (1 H, dd, J = 2.23 Hz, 3.71
 
Hz), 4.05-4 .00 (1 H, m), 2.71-2.63 (1 H, dd, J = 9.16 Hz, 15.11Hz, Ha-I) ,
 
2.58-2.52 (1 H, dd, J = 4.40 Hz, 15.11Hz, Hb-I ),2.07-2.04 (12 H, 4 x s,
 
OCOCHJ).
 
13C NMR (75 MHz, CDC!)): 8:170.6 (C-2'), 169.8, 169.6, 169.5, 168.9
 
(O~OCHJ), 144.9 (C-4'), 131.1 (C-T), 122.4 (C-5'), 120.4 (C-8'), 71.8 (C-1),
 
70.0 (C-5), 69.2 (C-2), 68.0 (C-4), 67.3 (C-3), 61.6 (C-6) , 52.7 (C-6'), 36.8 (C-3'), 
34.8 (C-I '),20 .8,20.7,20.7 (CHJ). 
+ +MS (ESI): 511.4 [ M+H] ,calcd. 511.21 for C22HJoN40 IO + H 
V.2.2 Synthesis of compound 126 
~8' 
5' N 7'2' HJj('I 
"N N N 
3'o 
Deprotection of acetylated 125 was accomplished following the 'Standard 
Zemplen deacetylation procedure' described above. 
Yield: 83 % 
Rf: 0.13 (Methanol: dichloromethane 20: 80) 
[afoo +23.5 (c = 1, CHJ OH) 
'n NMR (300 MHz, CDJOD): 87.87 (1 H, s, H-5'), 6.12-5 .99 (I H, m, H-T), 
5.32-5 .21 (2 H, m), 5.00-4.98 (2 H, d, J = 5.77 Hz), 4.46-4.44 (2 H, d, J = 6.32 Hz, 
115 
H-6 ' ), 4.30-4.27 (1 H, m), 3.87-3.8 1 (1 H, m), 3.73-3.64 (4 H, m), 3.59-3.57 (1 H, 
b), 2.67-2 .2.59 (1 H, dd, J = 9.6IHz, 14.83Hz, Ha-1 ' ), 2.56-2.4 9 (1 H, dd, J = 
4.81Hz, 14.97 Hz, Hb-1 ') . 
I3C NMR (75 MHz, CD30D): 8 173.3 (C-2' ), 146.5 (C-4'), 133.2 (C-7'), 124.3 
(C-5' ), 119.9 (C-8 '), 77.6 (C-5), 73.9 (C-1), 72.4 (C-3), 71.7 (C-2), 69.6 (C-4), 
62.2 (C-6), 53.6 (C-6'), 37.5 (C-3'),35.8 (C- I ' ).
 
MS (ESI): 343 .4 [M+Ht, calcd. 343. 16 for C14H22N406 + H+
 
VI Synthesis of a-D-mannopyranoside derivatives modified 
at position 1 with elongated carbon chain 
VI.1 2, 3, 4, 6-tetra -O-acetyl-a-D-mannopyranosyl bromide 127 
ACXl;0AcO 
AcO -0 
AcO 
Sr 
Mannose penta acetate (5.0 g, 12.81 mmo1) was dissolved in dichlorornethane 
(80 m1) and HBr/AcOH (33%) was added. The reaction mixture was stirred at 
room temperature for 2 h, and NaHC03 was added to quench the react ion. The 
mixture was washed with NaHC03 and water. The organic layer was dried over 
Na2S04, filter ed and concentrated to give 127 (3.967 g, 9.65 mmol). The crude 
product was used directly without further purifi cation. 
Yield: 75.3 % 
'n NMR (300 MHz, CDClJ): 86 .26-6.25 (1 H, d, J = 1.10 Hz, H-1), 5.67-5. 62 (1 
H, dd, J = 3.30, 10.16 Hz, H-3), 5.40-5. 38 (1 H, dd, J = 1.37, 3.30 Hz, H-2), 
5.35-5.28 (1 H, t, J = 10.16 Hz, H-4), 4.30-4.25 (1 H, dd, J = 4 .67, 12.36 Hz, 
116 
Ha-6), 4.19-4.14 (1 H, m, H-5), 4.10-4.05 (I H, dd, J = 1.92, 12.36 Hz, Hb-6). 
VI.2 Methyl 3-(O-tetraacetyl a-D-mannopyranosyl)propanoate 128 
AC~OAcO
-0 
AcO 
AcO 0 
OMe 
A solution of 2, 3, 4, 6-tetra-O-acetyl-a-D-mannopyranosyl bromide 127 
(2.914 g, 7.09 mmol) and methyl acrylate (1.15 ml, 33.39 mmol) in degassed 
toluene was stirred at 85°C and a solution of BU3SnH (2.1 ml, 7.9 mmol) and 
AIBN (24 mg, 0.426 mmol) in toluene was added dropwise over 30 min. Then the 
stirring was continued for 0.5 h at 85°C and the residue was dried under high 
vacuum. The residual syrup was dissolved in CH3CN, washed with hexane, and 
concentrated and purified by flash column chromatography using EtOAc/Toluene 
(20%), obtained product 1.986 g. [41] 
Yield: 67 %
 
Rf: 0.50 (EtOAc: Toluene 5: 95)
 
[a]20D +8.04 (c = 1, CHCI3)
 
'n NMR (300 MHz, CDCl3): 8 5.26-5.22 (1 H, dd, J = 3.30, 8.52 Hz, H-3), 
5.20-5 .17 (I H, d, J = 7.69 Hz, H-2), 5.15-5.13 (1 H, t, J = 3.30 Hz, H-4), 4.40 (1 
H, dd, J = 6.59, 12.36 Hz, Ha-6), 4.07-4.02 (I H, dd, J = 3.02, 12.09 Hz, Hb-6), 
4.01-3 .95 (1 H, m, H-5), 3.90-3 .85 (1 H, m, H-I), 3.68 (3 H, s, OCH3), 2.46-2.40 
(2 H, m, CH2CfuCO), 2.11-2.02 (12 H, 4 x s, 4 x CH3), 1.86-1.96 (2 H, m, 
CfuCH2CO). 
13 · .C NMR (75 MHz, CDC!)): 8 173.0 (~02CH3), 170.6, 170.1, 169.8, 169.6 (4 x 
CH3~O), 73.5 (C-I), 70 .7 (C-5), 70.3 (C-2), 68.7 (C-3), 66.9 (C-4), 62.1 (C-6), 
51.8 (C02~H 3) , 29.7 (CH 2~H2C=O), 23.9 ~H2CH2C=O), 20.9 , 20.7, 20.7, 20.6 
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VI.3 Methyl 3-(a-D-mannopyranosyl) propanoate 129 
HO~OH~OH~O 0 
OMe 
The Methyl 3-(a-D-mannopyranosyl) propanoate 128 (138 mg , 0.33 m11101) 
was dissolved in methanol (3 ml) followed by the addition of aIM solution of 
sodium methoxide in methanol (0.33 ml). The reaction mixture was stirred 
overn ight at room temperature and neutralized with Amberlite IR-120 (H+) resin, 
filtered and evaporated under reduced pressure. The residue was lyophilized to 
afford 129 (79 mg) as a solid . [41] 
Yield: 96% 
Rf: 0.05 (Methanol: EtOAc 10: 90) 
[a]20D +20 .8 (c = 1, CH30H) 
'n NMR (300 MHz, D20): 83 .75 (2 H, bs, Hsugar), 3.65 (2 H, bs, Hsugar) , 3.57 (4 
H, s, en, and Hsugar) , 3.50 (1 H, bs, Hsugar) , 3.46 (1 H, bs , Hsugar), 2.36 (2 H, bs, 
CH2CH2CO), 1.98 (1 H, bs , CH2CH2CO), 1.69 (1 H, bs, CfuCH2CO). 
"c NMR (75 MHz, D20): 8 176.5 (C=O), 77.7 (C-l), 73.8 (C-5), 71.5 (C-3) , 
70.9 (C-2), 67.4 (C-4), 61.3 (C-6) , 52.4 (CH 3) , 30.3 (CH2~H 2CO), 23.0 
(.GH2CH2CO). 
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VII Synthesis of manopyranoside derivatives modified 
at position 1 (O-mannoside) 
VII.1 Synthesis of 2,3,4,6-tetra-O-acetyl-a-D-mannopyranosyl -3'-phenyl 
-3'-propylene ether 131 
A~CCO
AcO -0 6' 
AcO ~'5' y--' I 7' 
o " :::::-... 
l' '" 3' 4' 5' 6' 
To solution of ally12,3,4,6-tetra-O-acetyl-a-D-mannopyranoside 130 (258 
mg, 0.664 mmol) in DCM (6 ml), styrene (0.152 ml, 1.328 mmol) and Grubbs 
catalyst (first generation, 23 mg, 0.028 mmol) were added, and the mixture was 
refluxed overnight. The solvent was then evaporated under reduced pressure, and 
the residue was purified by flash chromatography on silica gel (DCM/Hexane = 
70%) to afford 131 (214 mg) as an oil. 
Yield : 69 % 
Rf: 0.81 (Methanol: dichloromethane 5: 95) 
[a]20D +57.5 (c = I, CHC!]) 
IH NMR (300 MHz, CDCl3): 87.42-7.32 (5 H, m, H8romomatic), 6.66-6.61 (I H, d, 
J== 15.66 Hz, H-3'), 6.31-6 .22 (I H, m, H-2'), 5.43-5.38 (I H, dd,J== 3.44,10.03 
Hz), 5.36-5.28 (2 H, m), 4.943-4.937 (I H, d, J = 1.65 Hz, H-I), 4.39-4.27 (2 H, 
m, H-I'), 4.24-4 .20 (1 H, dd, J= 6.87,12.64 Hz), 4.15-4.10 (1 H, dd, J== 2.47, 
12.36 Hz), 4.09-4 .04 (1 H, m), 2.16-2.00 (12 H, 4 x s, 4 x OCOCH3) 
13C NMR (75 MHz, CDC!)): 8 170.6, 169.9, 169.8, 169.7 (O~OCHJ), 136.1 
(C-4'), 134.0 (C-3'), 128.6 (C-6'), 128.0 (C-7'), 126.5 (C-5'), 123.8 (C-2'), 96.4 
119 
(C-I), 69.6 (C-2), 69. 1 (C-5), 68 .5 (C-4), 68.3 (C-3), 66.1 (C-6), 62.4 (C-I '),20.8,
 
20.7, 20.6 ( OCO~1-I 3 ). 
VII.2 Synthesis of a-D-mannopyranosyI3 '-phenyl-3 '-propylene ether 132 
H~?-O\H~o~~,
5' ;' 17' 
o ~<c-, 
<, 6' 
l' 3' 4' 5' 
Deprotection of acetylated 131 was acco mplished followin g the 'S tanda rd 
Zemplen deacetylat ion proce dure' describ ed above. 
Yield: 95 % 
Rf: 0.05 (Methanol: dichloromethane 5: 95) 
[CX]20 D +80 .2 (c = I , CI-I3 0 1-1) 
'n NMR (300 MHz, CD30D): 8 7.4 1-7.38 (2 H, m, Haromatic), 7.31-7. 21 (3 H, m, 
Haromalic), 6.66 -6.6 1 (1 1-1 , d, J = 15.93 Hz, H-3 '), 6.37-6.28 ( I H, td, J = 6.04, 
15.93 Hz , H-2 ' ), 4.86 ( I H, H-I ), 4.39-4.32 ( I H, ddd , J = 1.37, 5.49, 12.91 Hz, 
Ha-I ') , 4 .20-4. 13 (1 H, ddd, J= 1.37,6.53,1 2.91 Hz, Hb-I '), 3.88-3.8 1 (2 H, m), 
3.77-3.70 (2 H, m), 3.66 -3.60 (2 H, m). 
13C NMR (75 MHz, CD30D): 8 138.1 (C-4'), 133.9 (C-3'), 129.6 (C-6'), 128.7 
(C-7'), 127.5 (C-5 ' ), 126.3 (C-2 ' ), 100.7 (C-I), 74.7 (C-5), 72.6 (C-2), 72.2 (C-3), 
68.6 (C-4 ), 62.9 (C-6) . 
MS (ESI): 319.1 [M+Nat, calc d. 3 19.11 for C I9H26N407 + Na+ 
VII.3 Synthesis of a -D-mannopyranosyl 3 '-phenyl-3 '-propane ether 133 
120 
H~?-O\H~04~,
5' ;' 17' 
o ~ 
6' 
l' 3' 4' 5' 
To solution of 132 (37 mg, 0.125mmol) in ethanol (3 ml) Pd/C catalyst (10%) 
was added, and the mixture was stirred at room temperature overnight. Pd/C was 
then filtered over Celite, the filtrate was evaporated under reduced pressure, and 
the residue was lyophilized to afford 133 (36 mg) as a white solid. 
Yield: 97 % 
Rf: 0.50 (Methanol : dichloromethane 15: 85) 
[a]20D+46.4 (c = 1, CH3OH) 
I H NMR (300 MHz, CD30D): 8 7.27-7.14 (5 H, m), 4.723 -4.718 (1 H, d, J = 
1.73 Hz, H-l), 3.81-3 .59 (6 H, m, Ha-l', 5 x Hsugar), 3.55-3 .52 (1 H, m), 3.44-3.36
 
(1 H, rn, Hb-l '),2.71-2.65 (2 H, m, H-3'), 1.93-1.86 (2 H, m, H-2 ').
 
I3 C NMR (75 MHz, CD30D): 8 143.1 (C-4'), 129.4 (C-6'), 129.4 (C-5'), 126.8
 
(C-T), 101.6 (C-l), 74.6 (C-5), 72.7 (C-2), 72.2 (C-3), 68 .6 (C-4), 67.8 (C-6),
 
62 .8 (C-l '),33.4 (C-3'), 32.4 (C-2').
 
MS (ESI): 321.1 [M+Nar, calcd. 321.13 for CI9H26N407 + Na+
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VIII Synthesis of a-D-manopyranoside derivatives modified at 
position 6 
VIII.! Methyl 6-azido-6-deoxy-a-D-mannopyranoside 135 
VIII.I.! Methyl 6-0-toluenesulfonyl-a-D-mannopyranoside 134 
' 2' 
4' I ~:0
3 
3' h IP 
2' l' liS" 
o O~HO
-0 H~o 
OMe 
Methyl a, O-mannopyranoside (5.00g, 25.7 mmol) was dissolved in pyridine 
(75 ml) and the solution was cooled to 0 °c, after which toluenesulfonyl chloride 
(6g, 31.5 mmol) was added in portions. The reaction was stirred at room 
temperature and the reaction was monitored by TLC. The pyridine was then co­
evaporated with toluene under reduced pressure. The residue was purified by flash 
column chromatography using Methanol/OCM (3.5%) and afforded the purified 
compound as colorless syrup [42] (6.835 g, 19.6 mmol). 
Yield: 93.1%
 
Rf: 0.22 (Methanol: dichloromethane 1: 9)
 
'n NMR (300 MHz, CDCh): 8 7.80 (2 H, d, J = 7.8 Hz), 7.33 (2 H, d, J = 7.8
 
Hz), 4.67 (1 H, s), 4.32 (2 H, m), 3.91 (1 H, m), 3.73 (2 H, m), 3.29 (3 H, s,
 
OCH 3) , 2.43 (3 H, S, CH3) .
 
13C NMR (75 MHz, CDCh): 8 145.2 (C-4') , 132.8 (C-l'), 130.2 (C-3'), 128.3
 
(C-2'), 101.2 (C-l), 71.9 (C-2, C-5) , 70.7 (C-3), 70.3 (C-4), 70.1 (C-6), 55.2
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VIII.1.2 Methyl 6-azido-6-deoxy-a-D-mannopyranoside 135 
N~HO-0 H~O 
OMe 
Compound 134 (1.005 g, 2.88 mmol) was dissolved in 15 ml of dry DMF, 
and the solution was heated to 60°C. Sodium azide (2 .06 g, 31.73 mmol) was 
then added in portions. When TLC indicated that all of the starting material had 
disappeared, the white precipitate was removed by vacuum filtration and the 
solvent was evaporated under vacuum. Column chromatography purification of the 
crude product provided 1~5 (0.4 g) as a colorless syrup . (42] 
Yield: 63% 
Rf: 0.31 (Methanol: dichloromethane 4%) 
IH NMR (300 MHz, CD30D): 84.64 (1 H, d, J= 1.5 Hz, H-l) , 3.80 (1 H, dd, J 
= 3.0, 1.5 Hz, H-2), 3.65-3.60 (2 H, m, H-3 and H-5), 3.58 (I H, t, J = 9.1 Hz, 
H-4), 3.48 (1 H, dd, J = 2.5, 13.2 Hz, Ha-6), 3.43 (1 H, dd, J = 7.1, 13.2 Hz, 
Hb-6) . 
13C NMR (75 MHz, CD30D): 8 101.0 (C-I), 71.4 (C-2), 71.2 (C-3), 70.7 (C-4), 
68.2 (C-5), 55.2 (OCH 3), 51.3 (C-6). 
VIII.2 Methyl 6-amino-6-deoxy-a-D-mannopyranoside 136 
123 
The compound 135 (0.40 g, 1.82 mmol) was dissolved in 35 ml of methanol, 
to which was added Pd/C as catalyst. The reaction was stirred at room temperature 
for 17 h under a hydrogen atmosphere. The mixture was filtered through Ce1ite, and 
the filtrate was concentrated to a very small volume. Flash column chromatography 
of the residue with CH2Ch/CH30H (2: 1 to 1:1) as eluting solvent provided f (250 
mg, 1.29 mmo1) as a colorless solid. [42] 
Yield: 70.6% 
I H NMR (300 MHz, CD30D): 04.47 (1 H, s, H-1), 3.57 (1 H, m, H-2), 3.40 (1 H, 
dd, J = 3.3,9.3 Hz , H-3), 3.33 (1 H, t, J = 9.3 Hz, H-4), 3.23 (1 H, s, OCH3) , 3.16 
(1 H, dt, J = 3.3, 7.4 Hz, H-5), 2.81 (1 H, dd, J = 3.0, 13.2 Hz , Ha-6), 2.58 (1 H, 
dd , J = 7.1, 13.2 Hz, Hb-6). 
13C NMR (75 MHz, CD30D): 0 101.1 (C-1), 73.8 (C-2), 70.9 (C-3), 70.2 (C-4), 
68.5 (C-5) , 53.9 (OCH3) , 43.3 (C-6). 
VIII.3 Synthesis of triazoles at position 6 
VIII.3.1 Synthesis of compound 138 
9fOH 
81 N 7~W\NOAC
 
-0 
AcO 
AcO 
OMe 
Synthesis of compound 138 was accomplished by following the 'General 
procedure of click chemistry' described above using methyl 6-azido-6-deoxy-2, 3, 
4-tri-O-acetyl a-D-mannopyranoside and propargyl alcohol. 
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Yield : 20%
 
Rf: 0.34 (Methanol: dichlorornethane 1: 9)
 
[a]20D+29.1 (c = 1, CHCI 3) 
'n NMR (300 MHz, CDC!)): 87.72 (1 H, s, H-7'), 5.34-5 .30 (1 H, dd, J = 2.93, 
10.03 Hz, H-3), 5.23-5.21 (1 H, dd,J = 1.79,3.44 Hz, H-2), 5.16-5 .09 (1 H, t,J= 
10.03 Hz, H-4) , 4.79 (2 H, s, H-9), 4.643-4.637 (1 H, d, J =1 .65 Hz, Ha-6) , 
4.63-4 .57 (l H, dd, J= 2.47 , 14.29 Hz, H-l), 4.44-4 .36 (1 H, dd, J = 8.65,14.15 
Hz, Hb-6), 4.18-4.10 (1 H, td, J= 2.47,10.16 Hz, H-5) , 3.11 (3 H, s, CH3), 2.14 
(3 H, s, OCOCH3), 2.11 (3 H, s, OCOCH3), 1.99 (3 H, S, OCOCH3). 
l3 C NMR (75 MHz, CDCI3) : 8 170.1, 169.9, 169.7 (O~OCH 3), 147.7 (C-8), 
123.3 (C-7), 98.4 (C-l), 69.3 (C-2), 69.1 (C-4), 68.7 (C-3), 67.3 (C-5) , 56.3 (C-9), 
55.3 (C-6) , 50.9 (OCHJ), 20.8, 20.7, 20.6 (OCO~H J) . 
MS (ESI): 402.4 [M+Ht, calcd.402.15 for C1 6HnNJ09 + H+ 
VIII.3.2 Synthesis of compound 139 
9(OAC 
8(~ 
7±:t;N
~N OAc 
AcO -0 
AcO 
OMe 
Synthesis of compound 139 was accomplished by following the 'General 
procedure of click chemistry ' des cribed above using methyl 6-deoxy-6-azido-2, 3, 
4-tri-O-acetyl a-D-mannopyranos ide and acetyl propargyl alcohol. 
Yield : 43% 
Rf: 0.49 (Methanol : dichloromethane 5: 95) 
[afoD +23.4 (c = 1, CHCl}) 
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I H NMR (300 MHz, CDC!)): 07.76 (1 H, s, H-7), 5.30-5.25 (1 H, m, H-3), 5.18 
(1 H, m, H-2), 5.19-5 ~12 (2 H, m, H-9), 5.10-5 .06 (1 H, dd, J = 1.92,9.89 Hz, 
H-4) , 4.61 (1 H, s, H-1), 4.61-4.55 (1 H, m, Ha-6), 4.40-4.32 (1 H, dd,J= 8.79, 
14.29 Hz, Hb-6), 4.11-4 .05 (1 H, td, J = 9.89, 1.92 Hz, H-5), 3.05 (3 H, s, CHJ), 
2.10 (3 H, s, OCOCHJ), 2.07 (3 H, s, OCOCHJ), 2.00 (3 H, s, OCOCHJ), 1.95 (3 
H, S, OCOCHJ). 
13C NMR (75 MHz, CDCl3) : 8 170.9, 170.3, 170.0, 169.9 (O~OCHJ) , 143.0 
(C-8), 125.2 (C-7), 98.6 (C-1), 69.5 (C-2), 69.2 (C-4) , 68.8 (C-3), 67.5 (C-5), 57.7 
(C-9), 55.4 (C-6), 51.2 (OCHJ), 21.0 ((OCO~H J), 20.9 ((OCO~H J), 20.8 
(OCO~HJ). 
+ +MS (ESI): 444.4 [M+H ] , calcd. 444.16 for C,sI-bNJOIO + H 
VIII.3.3 Synthesis of compound 140 
Deprotection of acetylated 139 was accomplished following the 'Standard 
Zernplen deacety1ation procedure ' described above. 
Yield: 55% 
Rf: 0.26 (Methanol: dich1oromethane 2: 8) 
[afoo +63.5 (c = 1, CHJOH) 
'H NMR (300 MHz, CD30D): ~ 7.96 (1 H, s, H-7), 4.87-4.82 (1 H, dd, J= 2.20, 
14.29 Hz), 4.66 (2 H, s, H-9), 4.57 (1 H, s), 4.52-4.47 (1 H, dd, J = 8.51, 14.01 
Hz), 3.82-3.76 (2 H, m, H-1, Ha-6), 3.68-3.64 (1 H, dd, J = 3.30, 9.34 Hz, Hb-6), 
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3.64-3.47 (1 H, t,J= 9.48 Hz, H-5), 3.07 (3 H, s, CH)). 
l3C NMR (75 MHz, CD30D): 8 148.9 (C-8), 125.5 (C-7), 102.8 (C-I), 72.8 
(C-2), 72.4 (C-3), 71.9 (C-4), 69.7 (C-5), 56.4 (C-9), 55.2 (C-6), 52.5 (OCH)). 
+ i:" +MS (ESI): 276.4 [M+H] , calcd . 276.12 lor C IOH 17N)0 6+ H 
VIllA Synthesis of other triazoles at position 6 
VIJIA.1 Synthesis of compound 142 
2' l' 3' 
N 8' 
N' \ g' ' N OAc 
A 0 ~O 
1::,0 
'Aco~
 
OMe 
Synthesis of compound 142 was accomplished by following the 'General 
procedure of click chemistry' described above using methyl 6-deoxy-6-azido-2, 3, 
4-tri-O-acetyl-a-D-mannopyranoside and propargyl 2', 3', 4' , 6' -tetra-G-acetyl­
a-D-mannopyranoside. 
Yield: 60 % 
Rf: 0.46 (Methanol: dichloromethane 5: 95) 
[a]20o +49.0 (c = 1, CHCl )) 
'n NMR (300 MHz, CDC!)): 87.71 (1 H, s, H-9'), 5.28-5 .21 (3 H, m), 5.17-5.06 
(3 H, m), 4.88 (1 H, s), 4.81-4 .77 (1 H, d, J =12.09 Hz), 4.64-4 .54 (3 H, m), 
4.39-4.31 (1 H, m), 4.26-4.20 (l H, dd, J = 4.95, 12.09 Hz), 4.12-3.99 (3 H, m), 
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3.02 (3 H, s, CH 3), 2.10-2.05 (12 H, m, OCOCH3), 1.97-1.91 (9 H, m, OCOCH3).
 
l3 C NMR (75 MHz, CDCI3): 8 170.4, 170.0, 169.8, 169.7, 169.5, 169.5
 
(O~OCH3), 143.3 (C-8 '), 124 .3 (C-9'), 98 .2 (C-l), 96.6 (C-l '),69.1 (C-2') , 68 .9
 
(C-4), 68.8 (C-2), 68.5 (C-5'), 68.5 (C-4'), 67.3 (C-3), 65 .8 (C-3'), 62.2 (C-6',
 
C-5), 60.7 (C-T), 55.0 (C-6), 50.9 (OCH3), 20.6, 20.6, 20.5, 20.4 (OCO~H3).
 
MS (ESI): 732.4 [M+Ht, calcd.732.25 for C30~IN401 8 + H+
 
VIII.4.2 Synthesis of compound 143 
2' l' 3' 
N 8' 
N' \ 9' ' N OH -Ii
,0 
~~O H~O 
OMe 
Deprotection of acetylated 142 was accomplished following the 'Standard 
Zernplen deacetylation procedure' described above. 
Yield: 78% 
Rf: 0.56 (Methanol: dichloromethane I : I) 
[a]20D +93.6 (c = 1, CH30H) 
IH NMR (300 MHz, CD 30D): 8 8.09 (1 H, s, H-9'), 4 .84-4.77 (2 H, m), 
4.67-4.48 (3 H, m), 3.88-3.47 (11 H, m), 3.07 (3 H, s, CH 3) . 
13C NMR (75 MHz, CD 30D): 8 145 .0 (C-8'), 126.9 (C-9'), 102.8 (C-I), 100.5 
(C-I '), 75.0 (C-5'), 72.8 (C-2'), 72 .5 (C-2), 72.4 (C-3'), 72 .0 (C-3), 71.9 (C-4), 
69.6 (C-4'), 68.6 (C-5), 63.0 (C-6'), 60.4 (C-T), 55.2 (C-6), 52 .6 (OCH3). 
MS (ESI): 438.4 [M+Ht, calcd.438.18 for C16H27N3011 + I-t 
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